{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "from typing import Any, Dict, List, Optional, get_args, get_origin, get_type_hints, Union, Annotated\n",
    "from pydantic import BaseModel, ValidationError, validator , model_validator, field_validator\n",
    "from pydantic.fields import Field\n",
    "from pydantic.functional_validators import AfterValidator\n",
    "from graphviz import Digraph\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "file_url = r\"C:\\Users\\Tommaso\\Documents\\Dev\\Abstractions\\data\\conversations.json\"\n",
    "file_url = \"/Users/tommasofurlanello/Documents/Dev/Abstractions/data/conversations.json\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "\n",
    "def load_first_record(file_path):\n",
    "    with open(file_path, 'r', encoding='utf-8') as file:\n",
    "        data = json.load(file)\n",
    "        if isinstance(data, list) and len(data) > 0:\n",
    "            return data[0]  # Return the first item in the list\n",
    "        else:\n",
    "            raise ValueError(\"JSON is not a list or is empty\")\n",
    "\n",
    "def load_nth_record(file_path, n):\n",
    "    with open(file_path, 'r', encoding='utf-8') as file:\n",
    "        data = json.load(file)\n",
    "        if isinstance(data, list) and len(data) > n:\n",
    "            return data[n]  # Return the nth item in the list\n",
    "        else:\n",
    "            raise ValueError(\"JSON is not a list or does not have enough items\")\n",
    "\n",
    "first_record = load_first_record(file_url)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'title': 'Access Denied, Master',\n",
       " 'create_time': 1710151351.377011,\n",
       " 'update_time': 1710151386.243972,\n",
       " 'mapping': {'bad6f1ec-e065-46ce-b96a-3b0dd11b6e66': {'id': 'bad6f1ec-e065-46ce-b96a-3b0dd11b6e66',\n",
       "   'message': {'id': 'bad6f1ec-e065-46ce-b96a-3b0dd11b6e66',\n",
       "    'author': {'role': 'system', 'name': None, 'metadata': {}},\n",
       "    'create_time': None,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'text', 'parts': ['']},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': True,\n",
       "    'weight': 0.0,\n",
       "    'metadata': {'is_visually_hidden_from_conversation': True},\n",
       "    'recipient': 'all'},\n",
       "   'parent': 'aaa135a9-3650-454d-9e77-4783d861c945',\n",
       "   'children': ['aaa2b64e-48b5-424a-9d94-8a554fab4981']},\n",
       "  'aaa135a9-3650-454d-9e77-4783d861c945': {'id': 'aaa135a9-3650-454d-9e77-4783d861c945',\n",
       "   'message': None,\n",
       "   'parent': None,\n",
       "   'children': ['bad6f1ec-e065-46ce-b96a-3b0dd11b6e66']},\n",
       "  'aaa2b64e-48b5-424a-9d94-8a554fab4981': {'id': 'aaa2b64e-48b5-424a-9d94-8a554fab4981',\n",
       "   'message': {'id': 'aaa2b64e-48b5-424a-9d94-8a554fab4981',\n",
       "    'author': {'role': 'user', 'name': None, 'metadata': {}},\n",
       "    'create_time': 1710151351.377609,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'text',\n",
       "     'parts': ['fix punctuation\\nBeware of him who would deny you access to information or in his heart he thinks himself your master']},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': None,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'request_id': '862ab598fd880dfb-AMS',\n",
       "     'timestamp_': 'absolute',\n",
       "     'message_type': None},\n",
       "    'recipient': 'all'},\n",
       "   'parent': 'bad6f1ec-e065-46ce-b96a-3b0dd11b6e66',\n",
       "   'children': ['833b2f3a-2d4c-44a0-a83b-b17d0759bd83']},\n",
       "  '833b2f3a-2d4c-44a0-a83b-b17d0759bd83': {'id': '833b2f3a-2d4c-44a0-a83b-b17d0759bd83',\n",
       "   'message': {'id': '833b2f3a-2d4c-44a0-a83b-b17d0759bd83',\n",
       "    'author': {'role': 'assistant', 'name': None, 'metadata': {}},\n",
       "    'create_time': 1710151352.53813,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'text',\n",
       "     'parts': ['Beware of him who would deny you access to information, for in his heart, he thinks himself your master.']},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': True,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'finish_details': {'type': 'stop', 'stop_tokens': [100260]},\n",
       "     'citations': [],\n",
       "     'gizmo_id': None,\n",
       "     'is_complete': True,\n",
       "     'message_type': None,\n",
       "     'model_slug': 'gpt-4',\n",
       "     'parent_id': 'aaa2b64e-48b5-424a-9d94-8a554fab4981',\n",
       "     'request_id': '862ab598fd880dfb-AMS',\n",
       "     'timestamp_': 'absolute'},\n",
       "    'recipient': 'all'},\n",
       "   'parent': 'aaa2b64e-48b5-424a-9d94-8a554fab4981',\n",
       "   'children': ['aaa23e46-fc9a-4d88-8deb-8aac924f9aaf']},\n",
       "  'aaa23e46-fc9a-4d88-8deb-8aac924f9aaf': {'id': 'aaa23e46-fc9a-4d88-8deb-8aac924f9aaf',\n",
       "   'message': {'id': 'aaa23e46-fc9a-4d88-8deb-8aac924f9aaf',\n",
       "    'author': {'role': 'user', 'name': None, 'metadata': {}},\n",
       "    'create_time': 1710151369.098633,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'text',\n",
       "     'parts': ['make a depiction of the concept']},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': None,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'request_id': '862ab6077ff50dfb-AMS',\n",
       "     'timestamp_': 'absolute',\n",
       "     'message_type': None},\n",
       "    'recipient': 'all'},\n",
       "   'parent': '833b2f3a-2d4c-44a0-a83b-b17d0759bd83',\n",
       "   'children': ['e9846981-ef02-4446-ae3d-d1ee15295b30']},\n",
       "  'e9846981-ef02-4446-ae3d-d1ee15295b30': {'id': 'e9846981-ef02-4446-ae3d-d1ee15295b30',\n",
       "   'message': {'id': 'e9846981-ef02-4446-ae3d-d1ee15295b30',\n",
       "    'author': {'role': 'assistant', 'name': None, 'metadata': {}},\n",
       "    'create_time': 1710151386.23856,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'code',\n",
       "     'language': 'json',\n",
       "     'text': '{\"size\":\"1024x1024\",\"prompt\":\"A symbolic representation of the concept \\'denial of information\\'. Visualize a figure, a personification of authority, imposingly standing with a large lock in his hand, symbolizing the restriction of access to a giant book or archive behind him. The background is a vast library, representing knowledge, but with chains around the books. The figure is silhouetted, exuding an aura of control and dominance, embodying the idea that withholding information is a form of power. The atmosphere is slightly ominous, highlighting the theme of censorship and the struggle for freedom of information.\"}'},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': False,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'finish_details': {'type': 'stop', 'stop_tokens': [100265]},\n",
       "     'gizmo_id': None,\n",
       "     'is_complete': True,\n",
       "     'message_type': None,\n",
       "     'model_slug': 'gpt-4',\n",
       "     'parent_id': 'aaa23e46-fc9a-4d88-8deb-8aac924f9aaf',\n",
       "     'request_id': '862ab6077ff50dfb-AMS',\n",
       "     'timestamp_': 'absolute'},\n",
       "    'recipient': 'dalle.text2im'},\n",
       "   'parent': 'aaa23e46-fc9a-4d88-8deb-8aac924f9aaf',\n",
       "   'children': ['4a44c386-47a9-4179-8f35-1ba87ed3eefb']},\n",
       "  '4a44c386-47a9-4179-8f35-1ba87ed3eefb': {'id': '4a44c386-47a9-4179-8f35-1ba87ed3eefb',\n",
       "   'message': {'id': '4a44c386-47a9-4179-8f35-1ba87ed3eefb',\n",
       "    'author': {'role': 'tool', 'name': 'dalle.text2im', 'metadata': {}},\n",
       "    'create_time': 1710151386.241205,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'multimodal_text',\n",
       "     'parts': [{'content_type': 'image_asset_pointer',\n",
       "       'asset_pointer': 'file-service://file-Y8b29zcLOvedUkgIDh7dYuQ9',\n",
       "       'size_bytes': 506722,\n",
       "       'width': 1024,\n",
       "       'height': 1024,\n",
       "       'fovea': 512,\n",
       "       'metadata': {'dalle': {'gen_id': '9frMWMALFJ2Qokbr',\n",
       "         'prompt': \"A symbolic representation of the concept 'denial of information'. Visualize a figure, a personification of authority, imposingly standing with a large lock in his hand, symbolizing the restriction of access to a giant book or archive behind him. The background is a vast library, representing knowledge, but with chains around the books. The figure is silhouetted, exuding an aura of control and dominance, embodying the idea that withholding information is a form of power. The atmosphere is slightly ominous, highlighting the theme of censorship and the struggle for freedom of information.\",\n",
       "         'seed': 1619700167,\n",
       "         'serialization_title': 'DALL-E generation metadata'}}}]},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': None,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'message_type': None,\n",
       "     'model_slug': 'gpt-4',\n",
       "     'parent_id': 'e9846981-ef02-4446-ae3d-d1ee15295b30',\n",
       "     'request_id': '862ab6077ff50dfb-AMS',\n",
       "     'timestamp_': 'absolute'},\n",
       "    'recipient': 'all'},\n",
       "   'parent': 'e9846981-ef02-4446-ae3d-d1ee15295b30',\n",
       "   'children': ['3bfa6eae-c452-4f74-89de-395569545ce0']},\n",
       "  '3bfa6eae-c452-4f74-89de-395569545ce0': {'id': '3bfa6eae-c452-4f74-89de-395569545ce0',\n",
       "   'message': {'id': '3bfa6eae-c452-4f74-89de-395569545ce0',\n",
       "    'author': {'role': 'tool', 'name': 'dalle.text2im', 'metadata': {}},\n",
       "    'create_time': 1710151386.241427,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'text',\n",
       "     'parts': [\"\\nDALL·E displayed 1 images. The images are already plainly visible, so don't repeat the descriptions in detail. Do not list download links as they are available in the ChatGPT UI already. The user may download the images by clicking on them, but do not mention anything about downloading to the user.\"]},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': None,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'message_type': None,\n",
       "     'model_slug': 'gpt-4',\n",
       "     'parent_id': '4a44c386-47a9-4179-8f35-1ba87ed3eefb',\n",
       "     'request_id': '862ab6077ff50dfb-AMS',\n",
       "     'timestamp_': 'absolute'},\n",
       "    'recipient': 'all'},\n",
       "   'parent': '4a44c386-47a9-4179-8f35-1ba87ed3eefb',\n",
       "   'children': ['bee92103-ed0b-4400-80dc-53c98b100bbc']},\n",
       "  'bee92103-ed0b-4400-80dc-53c98b100bbc': {'id': 'bee92103-ed0b-4400-80dc-53c98b100bbc',\n",
       "   'message': {'id': 'bee92103-ed0b-4400-80dc-53c98b100bbc',\n",
       "    'author': {'role': 'assistant', 'name': None, 'metadata': {}},\n",
       "    'create_time': 1710151386.241561,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'text',\n",
       "     'parts': ['Here is a depiction of the concept representing the denial of information, visualized through a symbolic representation.']},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': True,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'finish_details': {'type': 'stop', 'stop_tokens': [100260]},\n",
       "     'citations': [],\n",
       "     'gizmo_id': None,\n",
       "     'is_complete': True,\n",
       "     'message_type': None,\n",
       "     'model_slug': 'gpt-4',\n",
       "     'parent_id': '3bfa6eae-c452-4f74-89de-395569545ce0',\n",
       "     'request_id': '862ab6077ff50dfb-AMS',\n",
       "     'timestamp_': 'absolute'},\n",
       "    'recipient': 'all'},\n",
       "   'parent': '3bfa6eae-c452-4f74-89de-395569545ce0',\n",
       "   'children': []}},\n",
       " 'moderation_results': [],\n",
       " 'current_node': 'bee92103-ed0b-4400-80dc-53c98b100bbc',\n",
       " 'plugin_ids': None,\n",
       " 'conversation_id': '78a511be-2808-44b0-9600-99436d422b98',\n",
       " 'conversation_template_id': None,\n",
       " 'gizmo_id': None,\n",
       " 'is_archived': False,\n",
       " 'safe_urls': [],\n",
       " 'id': '78a511be-2808-44b0-9600-99436d422b98'}"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "first_record"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "class Author(BaseModel):\n",
    "    role: str\n",
    "    name: Optional[str] = None\n",
    "    metadata: Dict[str, Any] = {}\n",
    "\n",
    "class Content(BaseModel):\n",
    "    content_type: str\n",
    "    parts: Optional[Union[List[Union[str, Dict[str, Any]]], Dict[str, Any]]] = None\n",
    "    language: Optional[str] = None\n",
    "    text: Optional[str] = None\n",
    "\n",
    "    @field_validator('parts', mode= 'before')\n",
    "    def validate_parts(cls, v):\n",
    "        if isinstance(v, dict):\n",
    "            return [v]  # Wrap in a list if it's a dict\n",
    "        return v\n",
    "    def get_message_content(self):\n",
    "    # Check if text is provided\n",
    "        content = self\n",
    "        if content.text:\n",
    "            return content.text\n",
    "        # If text is None, try to get content from parts\n",
    "        elif content.parts:\n",
    "            # If parts is a list, we concatenate items or get the text from dict\n",
    "            if isinstance(content.parts, list):\n",
    "                # Concatenate list items if they are strings, or stringify them if they are dicts\n",
    "                return ' '.join(str(part) if isinstance(part, dict) else part for part in content.parts)\n",
    "            # If parts is a dict, we convert it to string\n",
    "            elif isinstance(content.parts, dict):\n",
    "                return str(content.parts)\n",
    "        return 'No message'\n",
    "\n",
    "class Message(BaseModel):\n",
    "    id: str\n",
    "    author: Optional[Author] = None\n",
    "    create_time: Optional[float] = None\n",
    "    update_time: Optional[float] = None\n",
    "    content: Optional[Content] = None\n",
    "    status: str\n",
    "    end_turn: Optional[bool] = None\n",
    "    weight: float\n",
    "    metadata: Dict[str, Any] = {}\n",
    "    recipient: str\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "from typing import List, Optional\n",
    "from pydantic import BaseModel\n",
    "\n",
    "\n",
    "\n",
    "class Node(BaseModel):\n",
    "    id: str\n",
    "    message: Optional[Message] = None\n",
    "    parent: Optional[str] = None\n",
    "    children: List[str] = []\n",
    "\n",
    "    def is_leaf(self) -> bool:\n",
    "        return len(self.children) == 0\n",
    "\n",
    "    def is_root(self) -> bool:\n",
    "        return self.parent is None\n",
    "\n",
    "    def is_linear(self) -> bool:\n",
    "        return len(self.children) <= 1 and (self.parent is None or self.parent.children == 1)\n",
    "\n",
    "class Conversation(BaseModel):\n",
    "    title: str\n",
    "    create_time: float\n",
    "    update_time: float\n",
    "    mapping: Dict[str, Node]\n",
    "    moderation_results: List[Any] = []\n",
    "    current_node: str\n",
    "    plugin_ids: Optional[Any] = None\n",
    "    conversation_id: str\n",
    "    conversation_template_id: Optional[Any] = None\n",
    "    gizmo_id: Optional[Any] = None\n",
    "    is_archived: bool\n",
    "    safe_urls: List[Any] = []\n",
    "    id: str\n",
    "\n",
    "    def extract_all_linearized_conversations(self) -> List['LinearConversation']:\n",
    "        def build_linear_conversations(node_id: str, current_path: Dict[str, Node], depth=0):\n",
    "            node = self.mapping[node_id]\n",
    "            new_node = node.model_copy(deep=True)\n",
    "            new_node.children = new_node.children[:1]  # Keep only the first child to ensure linearity\n",
    "\n",
    "            # Update the current path with the new linear node\n",
    "            new_path = {**current_path, new_node.id: new_node}\n",
    "\n",
    "            if not new_node.children:\n",
    "                # Leaf node, store the current path as a linear conversation\n",
    "                linear_conversations.append(LinearConversation(**{**self.model_dump(), \"mapping\": new_path}))\n",
    "            else:\n",
    "                # Recursively build the conversation for the next node in the path\n",
    "                build_linear_conversations(new_node.children[0], new_path, depth + 1)\n",
    "\n",
    "            # If the original node had multiple children, start new paths for each\n",
    "            if len(node.children) > 1:\n",
    "                for child_id in node.children[1:]:\n",
    "                    build_linear_conversations(child_id, current_path, depth + 1)\n",
    "\n",
    "        linear_conversations = []\n",
    "        for node_id, node in self.mapping.items():\n",
    "            if not node.parent:\n",
    "                build_linear_conversations(node_id, {})\n",
    "\n",
    "        return linear_conversations\n",
    "    \n",
    "    def visualize_conversation(self, filename: str = 'conversation_graph'):\n",
    "        graph = Digraph(comment=self.title)\n",
    "\n",
    "        def add_nodes_and_edges(node_id: str):\n",
    "            node = self.mapping[node_id]\n",
    "            if node.message and node.message.author:\n",
    "                author_role = node.message.author.role  # User or Assistant\n",
    "                # Use the get_message_content method to retrieve the message content\n",
    "                message_content = node.message.content.get_message_content() if node.message.content else \"No content\"\n",
    "                label = f\"{author_role}: {message_content}\"\n",
    "            else:\n",
    "                label = \"No message\"\n",
    "\n",
    "            graph.node(node_id, label=label)\n",
    "\n",
    "            for child_id in node.children:\n",
    "                graph.edge(node_id, child_id)\n",
    "                add_nodes_and_edges(child_id)\n",
    "\n",
    "        for node_id, node in self.mapping.items():\n",
    "            if node.is_root():\n",
    "                add_nodes_and_edges(node_id)\n",
    "\n",
    "        graph.render(filename, view=True, format='png')\n",
    "\n",
    "    \n",
    "def validate_single_child_node(node: Node) -> Node:\n",
    "    if len(node.children) > 1:\n",
    "        raise ValueError(\"Node has multiple children, not suitable for LinearConversation.\")\n",
    "    return node\n",
    "\n",
    "NodeWithSingleChild = Annotated[Node, AfterValidator(validate_single_child_node)]\n",
    "\n",
    "class LinearConversation(Conversation):\n",
    "    mapping: Dict[str, NodeWithSingleChild]\n",
    "\n",
    "    def __init__(self, **data: Any):\n",
    "        super().__init__(**data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'title': 'Access Denied, Master',\n",
       " 'create_time': 1710151351.377011,\n",
       " 'update_time': 1710151386.243972,\n",
       " 'mapping': {'bad6f1ec-e065-46ce-b96a-3b0dd11b6e66': {'id': 'bad6f1ec-e065-46ce-b96a-3b0dd11b6e66',\n",
       "   'message': {'id': 'bad6f1ec-e065-46ce-b96a-3b0dd11b6e66',\n",
       "    'author': {'role': 'system', 'name': None, 'metadata': {}},\n",
       "    'create_time': None,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'text', 'parts': ['']},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': True,\n",
       "    'weight': 0.0,\n",
       "    'metadata': {'is_visually_hidden_from_conversation': True},\n",
       "    'recipient': 'all'},\n",
       "   'parent': 'aaa135a9-3650-454d-9e77-4783d861c945',\n",
       "   'children': ['aaa2b64e-48b5-424a-9d94-8a554fab4981']},\n",
       "  'aaa135a9-3650-454d-9e77-4783d861c945': {'id': 'aaa135a9-3650-454d-9e77-4783d861c945',\n",
       "   'message': None,\n",
       "   'parent': None,\n",
       "   'children': ['bad6f1ec-e065-46ce-b96a-3b0dd11b6e66']},\n",
       "  'aaa2b64e-48b5-424a-9d94-8a554fab4981': {'id': 'aaa2b64e-48b5-424a-9d94-8a554fab4981',\n",
       "   'message': {'id': 'aaa2b64e-48b5-424a-9d94-8a554fab4981',\n",
       "    'author': {'role': 'user', 'name': None, 'metadata': {}},\n",
       "    'create_time': 1710151351.377609,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'text',\n",
       "     'parts': ['fix punctuation\\nBeware of him who would deny you access to information or in his heart he thinks himself your master']},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': None,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'request_id': '862ab598fd880dfb-AMS',\n",
       "     'timestamp_': 'absolute',\n",
       "     'message_type': None},\n",
       "    'recipient': 'all'},\n",
       "   'parent': 'bad6f1ec-e065-46ce-b96a-3b0dd11b6e66',\n",
       "   'children': ['833b2f3a-2d4c-44a0-a83b-b17d0759bd83']},\n",
       "  '833b2f3a-2d4c-44a0-a83b-b17d0759bd83': {'id': '833b2f3a-2d4c-44a0-a83b-b17d0759bd83',\n",
       "   'message': {'id': '833b2f3a-2d4c-44a0-a83b-b17d0759bd83',\n",
       "    'author': {'role': 'assistant', 'name': None, 'metadata': {}},\n",
       "    'create_time': 1710151352.53813,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'text',\n",
       "     'parts': ['Beware of him who would deny you access to information, for in his heart, he thinks himself your master.']},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': True,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'finish_details': {'type': 'stop', 'stop_tokens': [100260]},\n",
       "     'citations': [],\n",
       "     'gizmo_id': None,\n",
       "     'is_complete': True,\n",
       "     'message_type': None,\n",
       "     'model_slug': 'gpt-4',\n",
       "     'parent_id': 'aaa2b64e-48b5-424a-9d94-8a554fab4981',\n",
       "     'request_id': '862ab598fd880dfb-AMS',\n",
       "     'timestamp_': 'absolute'},\n",
       "    'recipient': 'all'},\n",
       "   'parent': 'aaa2b64e-48b5-424a-9d94-8a554fab4981',\n",
       "   'children': ['aaa23e46-fc9a-4d88-8deb-8aac924f9aaf']},\n",
       "  'aaa23e46-fc9a-4d88-8deb-8aac924f9aaf': {'id': 'aaa23e46-fc9a-4d88-8deb-8aac924f9aaf',\n",
       "   'message': {'id': 'aaa23e46-fc9a-4d88-8deb-8aac924f9aaf',\n",
       "    'author': {'role': 'user', 'name': None, 'metadata': {}},\n",
       "    'create_time': 1710151369.098633,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'text',\n",
       "     'parts': ['make a depiction of the concept']},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': None,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'request_id': '862ab6077ff50dfb-AMS',\n",
       "     'timestamp_': 'absolute',\n",
       "     'message_type': None},\n",
       "    'recipient': 'all'},\n",
       "   'parent': '833b2f3a-2d4c-44a0-a83b-b17d0759bd83',\n",
       "   'children': ['e9846981-ef02-4446-ae3d-d1ee15295b30']},\n",
       "  'e9846981-ef02-4446-ae3d-d1ee15295b30': {'id': 'e9846981-ef02-4446-ae3d-d1ee15295b30',\n",
       "   'message': {'id': 'e9846981-ef02-4446-ae3d-d1ee15295b30',\n",
       "    'author': {'role': 'assistant', 'name': None, 'metadata': {}},\n",
       "    'create_time': 1710151386.23856,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'code',\n",
       "     'language': 'json',\n",
       "     'text': '{\"size\":\"1024x1024\",\"prompt\":\"A symbolic representation of the concept \\'denial of information\\'. Visualize a figure, a personification of authority, imposingly standing with a large lock in his hand, symbolizing the restriction of access to a giant book or archive behind him. The background is a vast library, representing knowledge, but with chains around the books. The figure is silhouetted, exuding an aura of control and dominance, embodying the idea that withholding information is a form of power. The atmosphere is slightly ominous, highlighting the theme of censorship and the struggle for freedom of information.\"}'},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': False,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'finish_details': {'type': 'stop', 'stop_tokens': [100265]},\n",
       "     'gizmo_id': None,\n",
       "     'is_complete': True,\n",
       "     'message_type': None,\n",
       "     'model_slug': 'gpt-4',\n",
       "     'parent_id': 'aaa23e46-fc9a-4d88-8deb-8aac924f9aaf',\n",
       "     'request_id': '862ab6077ff50dfb-AMS',\n",
       "     'timestamp_': 'absolute'},\n",
       "    'recipient': 'dalle.text2im'},\n",
       "   'parent': 'aaa23e46-fc9a-4d88-8deb-8aac924f9aaf',\n",
       "   'children': ['4a44c386-47a9-4179-8f35-1ba87ed3eefb']},\n",
       "  '4a44c386-47a9-4179-8f35-1ba87ed3eefb': {'id': '4a44c386-47a9-4179-8f35-1ba87ed3eefb',\n",
       "   'message': {'id': '4a44c386-47a9-4179-8f35-1ba87ed3eefb',\n",
       "    'author': {'role': 'tool', 'name': 'dalle.text2im', 'metadata': {}},\n",
       "    'create_time': 1710151386.241205,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'multimodal_text',\n",
       "     'parts': [{'content_type': 'image_asset_pointer',\n",
       "       'asset_pointer': 'file-service://file-Y8b29zcLOvedUkgIDh7dYuQ9',\n",
       "       'size_bytes': 506722,\n",
       "       'width': 1024,\n",
       "       'height': 1024,\n",
       "       'fovea': 512,\n",
       "       'metadata': {'dalle': {'gen_id': '9frMWMALFJ2Qokbr',\n",
       "         'prompt': \"A symbolic representation of the concept 'denial of information'. Visualize a figure, a personification of authority, imposingly standing with a large lock in his hand, symbolizing the restriction of access to a giant book or archive behind him. The background is a vast library, representing knowledge, but with chains around the books. The figure is silhouetted, exuding an aura of control and dominance, embodying the idea that withholding information is a form of power. The atmosphere is slightly ominous, highlighting the theme of censorship and the struggle for freedom of information.\",\n",
       "         'seed': 1619700167,\n",
       "         'serialization_title': 'DALL-E generation metadata'}}}]},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': None,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'message_type': None,\n",
       "     'model_slug': 'gpt-4',\n",
       "     'parent_id': 'e9846981-ef02-4446-ae3d-d1ee15295b30',\n",
       "     'request_id': '862ab6077ff50dfb-AMS',\n",
       "     'timestamp_': 'absolute'},\n",
       "    'recipient': 'all'},\n",
       "   'parent': 'e9846981-ef02-4446-ae3d-d1ee15295b30',\n",
       "   'children': ['3bfa6eae-c452-4f74-89de-395569545ce0']},\n",
       "  '3bfa6eae-c452-4f74-89de-395569545ce0': {'id': '3bfa6eae-c452-4f74-89de-395569545ce0',\n",
       "   'message': {'id': '3bfa6eae-c452-4f74-89de-395569545ce0',\n",
       "    'author': {'role': 'tool', 'name': 'dalle.text2im', 'metadata': {}},\n",
       "    'create_time': 1710151386.241427,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'text',\n",
       "     'parts': [\"\\nDALL·E displayed 1 images. The images are already plainly visible, so don't repeat the descriptions in detail. Do not list download links as they are available in the ChatGPT UI already. The user may download the images by clicking on them, but do not mention anything about downloading to the user.\"]},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': None,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'message_type': None,\n",
       "     'model_slug': 'gpt-4',\n",
       "     'parent_id': '4a44c386-47a9-4179-8f35-1ba87ed3eefb',\n",
       "     'request_id': '862ab6077ff50dfb-AMS',\n",
       "     'timestamp_': 'absolute'},\n",
       "    'recipient': 'all'},\n",
       "   'parent': '4a44c386-47a9-4179-8f35-1ba87ed3eefb',\n",
       "   'children': ['bee92103-ed0b-4400-80dc-53c98b100bbc']},\n",
       "  'bee92103-ed0b-4400-80dc-53c98b100bbc': {'id': 'bee92103-ed0b-4400-80dc-53c98b100bbc',\n",
       "   'message': {'id': 'bee92103-ed0b-4400-80dc-53c98b100bbc',\n",
       "    'author': {'role': 'assistant', 'name': None, 'metadata': {}},\n",
       "    'create_time': 1710151386.241561,\n",
       "    'update_time': None,\n",
       "    'content': {'content_type': 'text',\n",
       "     'parts': ['Here is a depiction of the concept representing the denial of information, visualized through a symbolic representation.']},\n",
       "    'status': 'finished_successfully',\n",
       "    'end_turn': True,\n",
       "    'weight': 1.0,\n",
       "    'metadata': {'finish_details': {'type': 'stop', 'stop_tokens': [100260]},\n",
       "     'citations': [],\n",
       "     'gizmo_id': None,\n",
       "     'is_complete': True,\n",
       "     'message_type': None,\n",
       "     'model_slug': 'gpt-4',\n",
       "     'parent_id': '3bfa6eae-c452-4f74-89de-395569545ce0',\n",
       "     'request_id': '862ab6077ff50dfb-AMS',\n",
       "     'timestamp_': 'absolute'},\n",
       "    'recipient': 'all'},\n",
       "   'parent': '3bfa6eae-c452-4f74-89de-395569545ce0',\n",
       "   'children': []}},\n",
       " 'moderation_results': [],\n",
       " 'current_node': 'bee92103-ed0b-4400-80dc-53c98b100bbc',\n",
       " 'plugin_ids': None,\n",
       " 'conversation_id': '78a511be-2808-44b0-9600-99436d422b98',\n",
       " 'conversation_template_id': None,\n",
       " 'gizmo_id': None,\n",
       " 'is_archived': False,\n",
       " 'safe_urls': [],\n",
       " 'id': '78a511be-2808-44b0-9600-99436d422b98'}"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "first_record"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Conversation(title='Access Denied, Master', create_time=1710151351.377011, update_time=1710151386.243972, mapping={'bad6f1ec-e065-46ce-b96a-3b0dd11b6e66': Node(id='bad6f1ec-e065-46ce-b96a-3b0dd11b6e66', message=Message(id='bad6f1ec-e065-46ce-b96a-3b0dd11b6e66', author=Author(role='system', name=None, metadata={}), create_time=None, update_time=None, content=Content(content_type='text', parts=[''], language=None, text=None), status='finished_successfully', end_turn=True, weight=0.0, metadata={'is_visually_hidden_from_conversation': True}, recipient='all'), parent='aaa135a9-3650-454d-9e77-4783d861c945', children=['aaa2b64e-48b5-424a-9d94-8a554fab4981']), 'aaa135a9-3650-454d-9e77-4783d861c945': Node(id='aaa135a9-3650-454d-9e77-4783d861c945', message=None, parent=None, children=['bad6f1ec-e065-46ce-b96a-3b0dd11b6e66']), 'aaa2b64e-48b5-424a-9d94-8a554fab4981': Node(id='aaa2b64e-48b5-424a-9d94-8a554fab4981', message=Message(id='aaa2b64e-48b5-424a-9d94-8a554fab4981', author=Author(role='user', name=None, metadata={}), create_time=1710151351.377609, update_time=None, content=Content(content_type='text', parts=['fix punctuation\\nBeware of him who would deny you access to information or in his heart he thinks himself your master'], language=None, text=None), status='finished_successfully', end_turn=None, weight=1.0, metadata={'request_id': '862ab598fd880dfb-AMS', 'timestamp_': 'absolute', 'message_type': None}, recipient='all'), parent='bad6f1ec-e065-46ce-b96a-3b0dd11b6e66', children=['833b2f3a-2d4c-44a0-a83b-b17d0759bd83']), '833b2f3a-2d4c-44a0-a83b-b17d0759bd83': Node(id='833b2f3a-2d4c-44a0-a83b-b17d0759bd83', message=Message(id='833b2f3a-2d4c-44a0-a83b-b17d0759bd83', author=Author(role='assistant', name=None, metadata={}), create_time=1710151352.53813, update_time=None, content=Content(content_type='text', parts=['Beware of him who would deny you access to information, for in his heart, he thinks himself your master.'], language=None, text=None), status='finished_successfully', end_turn=True, weight=1.0, metadata={'finish_details': {'type': 'stop', 'stop_tokens': [100260]}, 'citations': [], 'gizmo_id': None, 'is_complete': True, 'message_type': None, 'model_slug': 'gpt-4', 'parent_id': 'aaa2b64e-48b5-424a-9d94-8a554fab4981', 'request_id': '862ab598fd880dfb-AMS', 'timestamp_': 'absolute'}, recipient='all'), parent='aaa2b64e-48b5-424a-9d94-8a554fab4981', children=['aaa23e46-fc9a-4d88-8deb-8aac924f9aaf']), 'aaa23e46-fc9a-4d88-8deb-8aac924f9aaf': Node(id='aaa23e46-fc9a-4d88-8deb-8aac924f9aaf', message=Message(id='aaa23e46-fc9a-4d88-8deb-8aac924f9aaf', author=Author(role='user', name=None, metadata={}), create_time=1710151369.098633, update_time=None, content=Content(content_type='text', parts=['make a depiction of the concept'], language=None, text=None), status='finished_successfully', end_turn=None, weight=1.0, metadata={'request_id': '862ab6077ff50dfb-AMS', 'timestamp_': 'absolute', 'message_type': None}, recipient='all'), parent='833b2f3a-2d4c-44a0-a83b-b17d0759bd83', children=['e9846981-ef02-4446-ae3d-d1ee15295b30']), 'e9846981-ef02-4446-ae3d-d1ee15295b30': Node(id='e9846981-ef02-4446-ae3d-d1ee15295b30', message=Message(id='e9846981-ef02-4446-ae3d-d1ee15295b30', author=Author(role='assistant', name=None, metadata={}), create_time=1710151386.23856, update_time=None, content=Content(content_type='code', parts=None, language='json', text='{\"size\":\"1024x1024\",\"prompt\":\"A symbolic representation of the concept \\'denial of information\\'. Visualize a figure, a personification of authority, imposingly standing with a large lock in his hand, symbolizing the restriction of access to a giant book or archive behind him. The background is a vast library, representing knowledge, but with chains around the books. The figure is silhouetted, exuding an aura of control and dominance, embodying the idea that withholding information is a form of power. The atmosphere is slightly ominous, highlighting the theme of censorship and the struggle for freedom of information.\"}'), status='finished_successfully', end_turn=False, weight=1.0, metadata={'finish_details': {'type': 'stop', 'stop_tokens': [100265]}, 'gizmo_id': None, 'is_complete': True, 'message_type': None, 'model_slug': 'gpt-4', 'parent_id': 'aaa23e46-fc9a-4d88-8deb-8aac924f9aaf', 'request_id': '862ab6077ff50dfb-AMS', 'timestamp_': 'absolute'}, recipient='dalle.text2im'), parent='aaa23e46-fc9a-4d88-8deb-8aac924f9aaf', children=['4a44c386-47a9-4179-8f35-1ba87ed3eefb']), '4a44c386-47a9-4179-8f35-1ba87ed3eefb': Node(id='4a44c386-47a9-4179-8f35-1ba87ed3eefb', message=Message(id='4a44c386-47a9-4179-8f35-1ba87ed3eefb', author=Author(role='tool', name='dalle.text2im', metadata={}), create_time=1710151386.241205, update_time=None, content=Content(content_type='multimodal_text', parts=[{'content_type': 'image_asset_pointer', 'asset_pointer': 'file-service://file-Y8b29zcLOvedUkgIDh7dYuQ9', 'size_bytes': 506722, 'width': 1024, 'height': 1024, 'fovea': 512, 'metadata': {'dalle': {'gen_id': '9frMWMALFJ2Qokbr', 'prompt': \"A symbolic representation of the concept 'denial of information'. Visualize a figure, a personification of authority, imposingly standing with a large lock in his hand, symbolizing the restriction of access to a giant book or archive behind him. The background is a vast library, representing knowledge, but with chains around the books. The figure is silhouetted, exuding an aura of control and dominance, embodying the idea that withholding information is a form of power. The atmosphere is slightly ominous, highlighting the theme of censorship and the struggle for freedom of information.\", 'seed': 1619700167, 'serialization_title': 'DALL-E generation metadata'}}}], language=None, text=None), status='finished_successfully', end_turn=None, weight=1.0, metadata={'message_type': None, 'model_slug': 'gpt-4', 'parent_id': 'e9846981-ef02-4446-ae3d-d1ee15295b30', 'request_id': '862ab6077ff50dfb-AMS', 'timestamp_': 'absolute'}, recipient='all'), parent='e9846981-ef02-4446-ae3d-d1ee15295b30', children=['3bfa6eae-c452-4f74-89de-395569545ce0']), '3bfa6eae-c452-4f74-89de-395569545ce0': Node(id='3bfa6eae-c452-4f74-89de-395569545ce0', message=Message(id='3bfa6eae-c452-4f74-89de-395569545ce0', author=Author(role='tool', name='dalle.text2im', metadata={}), create_time=1710151386.241427, update_time=None, content=Content(content_type='text', parts=[\"\\nDALL·E displayed 1 images. The images are already plainly visible, so don't repeat the descriptions in detail. Do not list download links as they are available in the ChatGPT UI already. The user may download the images by clicking on them, but do not mention anything about downloading to the user.\"], language=None, text=None), status='finished_successfully', end_turn=None, weight=1.0, metadata={'message_type': None, 'model_slug': 'gpt-4', 'parent_id': '4a44c386-47a9-4179-8f35-1ba87ed3eefb', 'request_id': '862ab6077ff50dfb-AMS', 'timestamp_': 'absolute'}, recipient='all'), parent='4a44c386-47a9-4179-8f35-1ba87ed3eefb', children=['bee92103-ed0b-4400-80dc-53c98b100bbc']), 'bee92103-ed0b-4400-80dc-53c98b100bbc': Node(id='bee92103-ed0b-4400-80dc-53c98b100bbc', message=Message(id='bee92103-ed0b-4400-80dc-53c98b100bbc', author=Author(role='assistant', name=None, metadata={}), create_time=1710151386.241561, update_time=None, content=Content(content_type='text', parts=['Here is a depiction of the concept representing the denial of information, visualized through a symbolic representation.'], language=None, text=None), status='finished_successfully', end_turn=True, weight=1.0, metadata={'finish_details': {'type': 'stop', 'stop_tokens': [100260]}, 'citations': [], 'gizmo_id': None, 'is_complete': True, 'message_type': None, 'model_slug': 'gpt-4', 'parent_id': '3bfa6eae-c452-4f74-89de-395569545ce0', 'request_id': '862ab6077ff50dfb-AMS', 'timestamp_': 'absolute'}, recipient='all'), parent='3bfa6eae-c452-4f74-89de-395569545ce0', children=[])}, moderation_results=[], current_node='bee92103-ed0b-4400-80dc-53c98b100bbc', plugin_ids=None, conversation_id='78a511be-2808-44b0-9600-99436d422b98', conversation_template_id=None, gizmo_id=None, is_archived=False, safe_urls=[], id='78a511be-2808-44b0-9600-99436d422b98')"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "conversation_instance = Conversation(**first_record)\n",
    "conversation_instance\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "conversation_instance.visualize_conversation()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(conversation_instance.extract_all_linearized_conversations())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "test_record = load_nth_record(file_url, 3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "title='Functional Criteria for Compound Order' create_time=1709851858.42512 update_time=1709852062.470933 mapping={'dc35e96e-78eb-434f-ad69-2f84416bb49c': Node(id='dc35e96e-78eb-434f-ad69-2f84416bb49c', message=Message(id='dc35e96e-78eb-434f-ad69-2f84416bb49c', author=Author(role='system', name=None, metadata={}), create_time=None, update_time=None, content=Content(content_type='text', parts=[''], language=None, text=None), status='finished_successfully', end_turn=True, weight=0.0, metadata={'is_visually_hidden_from_conversation': True}, recipient='all'), parent='aaa15694-6345-43a7-be05-1c5b4f73f9f6', children=['aaa239c1-beeb-4101-be6a-3b95dc9b0466', 'aaa2529d-3ccd-4f97-8907-35cddef7bef1', 'aaa2d260-4979-4b5d-acd7-24d658ade059', 'aaa270c8-9410-41ff-a995-8ced8fa2891c']), 'aaa15694-6345-43a7-be05-1c5b4f73f9f6': Node(id='aaa15694-6345-43a7-be05-1c5b4f73f9f6', message=None, parent=None, children=['dc35e96e-78eb-434f-ad69-2f84416bb49c']), 'aaa239c1-beeb-4101-be6a-3b95dc9b0466': Node(id='aaa239c1-beeb-4101-be6a-3b95dc9b0466', message=Message(id='aaa239c1-beeb-4101-be6a-3b95dc9b0466', author=Author(role='user', name=None, metadata={}), create_time=1709851858.426031, update_time=None, content=Content(content_type='text', parts=['find a rationale for this compound ordering \\nCompound: fluoxetine hydrochloride\\nCompound: labetalol\\nCompound: acarbose\\nCompound: nicotinic acid\\nCompound: ajmaline\\nCompound: carboplatin\\nCompound: ranitidine\\nCompound: benziodarone\\nCompound: butylated hydroxyanisole\\nCompound: danazol\\nCompound: omeprazole\\nCompound: chlormadinone\\nCompound: WY-14643\\nCompound: bendazac\\nCompound: simvastatin\\nCompound: griseofulvin\\nCompound: etoposide\\nCompound: nimesulide\\nCompound: 2,4-dinitrophenol\\nCompound: diclofenac\\nCompound: tiopronin\\nCompound: famotidine\\nCompound: pemoline\\nCompound: cyclophosphamide\\nCompound: triazolam\\nCompound: colchicine\\nCompound: dantrolene\\nCompound: perhexiline\\nCompound: ethanol\\nCompound: erythromycin ethylsuccinate\\nCompound: lomustine\\nCompound: doxorubicin\\nCompound: acetamidofluorene\\nCompound: tacrine\\nCompound: caffeine\\nCompound: captopril\\nCompound: azathioprine\\nCompound: flutamide\\nCompound: aspirin\\nCompound: carbon tetrachloride\\nCompound: nitrofurazone\\nCompound: nitrosodiethylamine\\nCompound: chlormezanone\\nCompound: moxisylyte\\nCompound: isoniazid\\nCompound: rotenone\\nCompound: naphthyl isothiocyanate\\nCompound: metformin\\nCompound: theophylline\\nCompound: sulfasalazine\\nCompound: adapin\\nCompound: nitrofurantoin\\nCompound: sulindac\\nCompound: cimetidine\\nCompound: sulpiride\\nCompound: clofibrate\\nCompound: benzbromarone\\nCompound: amiodarone\\nCompound: rosiglitazone maleate\\nCompound: hexachlorobenzene\\nCompound: propranolol\\nCompound: propylthiouracil\\nCompound: glibenclamide\\nCompound: allyl alcohol\\nCompound: ethionamide\\nCompound: tetracycline\\nCompound: carbamazepine\\nCompound: enalapril\\nCompound: ethinylestradiol\\nCompound: haloperidol\\nCompound: bucetin\\nCompound: ethionine\\nCompound: methapyrilene\\nCompound: methylene dianiline\\nCompound: lornoxicam\\nCompound: fluphenazine\\nCompound: rifampicin\\nCompound: methyldopa\\nCompound: phenylanthranilic acid\\nCompound: disulfiram\\nCompound: quinidine\\nCompound: ticlopidine\\nCompound: puromycin aminonucleoside\\nCompound: promethazine\\nCompound: bromobenzene\\nCompound: thioridazine\\nCompound: ethambutol\\nCompound: gemfibrozil\\nCompound: diltiazem\\nCompound: vitamin A\\nCompound: ciprofloxacin\\nCompound: phenobarbital\\nCompound: methyltestosterone\\nCompound: chlorpropamide\\nCompound: ibuprofen\\nCompound: nifedipine\\nCompound: tolbutamide\\nCompound: thioacetamide\\nCompound: clomipramine\\nCompound: bromoethylamine\\nCompound: trimethadione\\nCompound: coumarin\\nCompound: meloxicam\\nCompound: chlorpheniramine\\nCompound: fenofibrate\\nCompound: valproic acid\\nCompound: acetazolamide\\nCompound: terbinafine\\nCompound: triamterene\\nCompound: allopurinol\\nCompound: amphotericin B\\nCompound: desmopressin acetate\\nCompound: cephalothin\\nCompound: papaverine\\nCompound: amitriptyline\\nCompound: indomethacin\\nCompound: penicillamine\\nCompound: tamoxifen\\nCompound: furosemide\\nCompound: chlorpromazine\\nCompound: iproniazid\\nCompound: hydroxyzine\\nCompound: cyclosporine A\\nCompound: mexiletine\\nCompound: methimazole\\nCompound: acetamide\\nCompound: chloramphenicol\\nCompound: phalloidin\\nCompound: disopyramide\\nCompound: naproxen\\nCompound: monocrotaline\\nCompound: phenytoin\\nCompound: imipramine\\nCompound: acetaminophen\\nCompound: gentamicin\\nCompound: mefenamic acid\\nCompound: cisplatin\\nCompound: diazepam\\nCompound: phenylbutazone\\nCompound: 1% cholesterol + 0.25% sodium cholate\\nCompound: ketoconazole\\nCompound: phenacetin'], language=None, text=None), status='finished_successfully', end_turn=None, weight=1.0, metadata={'request_id': '860e25c1dc6f6728-AMS', 'timestamp_': 'absolute', 'message_type': None}, recipient='all'), parent='dc35e96e-78eb-434f-ad69-2f84416bb49c', children=['f91699b4-20a4-4b8b-b60c-89c5094cc682']), 'f91699b4-20a4-4b8b-b60c-89c5094cc682': Node(id='f91699b4-20a4-4b8b-b60c-89c5094cc682', message=Message(id='f91699b4-20a4-4b8b-b60c-89c5094cc682', author=Author(role='assistant', name=None, metadata={}), create_time=1709851868.602737, update_time=None, content=Content(content_type='text', parts=[\"Finding a rationale for ordering such a diverse list of compounds like the one you've provided can be challenging because it depends on the context or criteria you want to prioritize. However, I can suggest several possible rationales for organizing this list:\\n\\n1. **Alphabetical Order**: The simplest way is to arrange them alphabetically. This is straightforward and helps in quickly locating a specific compound in the list.\\n\\n2. **Therapeutic Use/Pharmacological Class**: Grouping the compounds based on their therapeutic use or pharmacological class can be useful. For example, grouping all antihypertensives, antibiotics, antidiabetics, or chemotherapeutic agents together.\\n\\n3. **Mechanism of Action**: Organizing the compounds based on their mechanism of action, such as enzyme inhibitors, receptor antagonists, ion channel blockers, etc.\\n\\n4. **Chemical Structure**: Compounds could be categorized based on their chemical structure or the presence of certain functional groups.\\n\\n5. **Toxicity Profile**: Arranging them based on their safety or toxicity profile, from those considered safest to those with high toxicity levels.\\n\\n6. **Clinical Application**: Sorting the compounds based on the range of clinical applications, from those used for common ailments to those\"], language=None, text=None), status='in_progress', end_turn=None, weight=1.0, metadata={'citations': [], 'gizmo_id': None, 'message_type': None, 'model_slug': 'gpt-4', 'parent_id': 'aaa239c1-beeb-4101-be6a-3b95dc9b0466', 'finish_details': {'type': 'interrupted'}, 'request_id': '860e25c1dc6f6728-AMS', 'timestamp_': 'absolute'}, recipient='all'), parent='aaa239c1-beeb-4101-be6a-3b95dc9b0466', children=[]), 'aaa2529d-3ccd-4f97-8907-35cddef7bef1': Node(id='aaa2529d-3ccd-4f97-8907-35cddef7bef1', message=Message(id='aaa2529d-3ccd-4f97-8907-35cddef7bef1', author=Author(role='user', name=None, metadata={}), create_time=1709851922.300042, update_time=None, content=Content(content_type='text', parts=['Help me understand why this compounds have this order. I know for certain they have been ordered under a functional criteria, but I do not know which one or which combinations and I need to try to reverse engineer it. \\nCompound: fluoxetine hydrochloride\\nCompound: labetalol\\nCompound: acarbose\\nCompound: nicotinic acid\\nCompound: ajmaline\\nCompound: carboplatin\\nCompound: ranitidine\\nCompound: benziodarone\\nCompound: butylated hydroxyanisole\\nCompound: danazol\\nCompound: omeprazole\\nCompound: chlormadinone\\nCompound: WY-14643\\nCompound: bendazac\\nCompound: simvastatin\\nCompound: griseofulvin\\nCompound: etoposide\\nCompound: nimesulide\\nCompound: 2,4-dinitrophenol\\nCompound: diclofenac\\nCompound: tiopronin\\nCompound: famotidine\\nCompound: pemoline\\nCompound: cyclophosphamide\\nCompound: triazolam\\nCompound: colchicine\\nCompound: dantrolene\\nCompound: perhexiline\\nCompound: ethanol\\nCompound: erythromycin ethylsuccinate\\nCompound: lomustine\\nCompound: doxorubicin\\nCompound: acetamidofluorene\\nCompound: tacrine\\nCompound: caffeine\\nCompound: captopril\\nCompound: azathioprine\\nCompound: flutamide\\nCompound: aspirin\\nCompound: carbon tetrachloride\\nCompound: nitrofurazone\\nCompound: nitrosodiethylamine\\nCompound: chlormezanone\\nCompound: moxisylyte\\nCompound: isoniazid\\nCompound: rotenone\\nCompound: naphthyl isothiocyanate\\nCompound: metformin\\nCompound: theophylline\\nCompound: sulfasalazine\\nCompound: adapin\\nCompound: nitrofurantoin\\nCompound: sulindac\\nCompound: cimetidine\\nCompound: sulpiride\\nCompound: clofibrate\\nCompound: benzbromarone\\nCompound: amiodarone\\nCompound: rosiglitazone maleate\\nCompound: hexachlorobenzene\\nCompound: propranolol\\nCompound: propylthiouracil\\nCompound: glibenclamide\\nCompound: allyl alcohol\\nCompound: ethionamide\\nCompound: tetracycline\\nCompound: carbamazepine\\nCompound: enalapril\\nCompound: ethinylestradiol\\nCompound: haloperidol\\nCompound: bucetin\\nCompound: ethionine\\nCompound: methapyrilene\\nCompound: methylene dianiline\\nCompound: lornoxicam\\nCompound: fluphenazine\\nCompound: rifampicin\\nCompound: methyldopa\\nCompound: phenylanthranilic acid\\nCompound: disulfiram\\nCompound: quinidine\\nCompound: ticlopidine\\nCompound: puromycin aminonucleoside\\nCompound: promethazine\\nCompound: bromobenzene\\nCompound: thioridazine\\nCompound: ethambutol\\nCompound: gemfibrozil\\nCompound: diltiazem\\nCompound: vitamin A\\nCompound: ciprofloxacin\\nCompound: phenobarbital\\nCompound: methyltestosterone\\nCompound: chlorpropamide\\nCompound: ibuprofen\\nCompound: nifedipine\\nCompound: tolbutamide\\nCompound: thioacetamide\\nCompound: clomipramine\\nCompound: bromoethylamine\\nCompound: trimethadione\\nCompound: coumarin\\nCompound: meloxicam\\nCompound: chlorpheniramine\\nCompound: fenofibrate\\nCompound: valproic acid\\nCompound: acetazolamide\\nCompound: terbinafine\\nCompound: triamterene\\nCompound: allopurinol\\nCompound: amphotericin B\\nCompound: desmopressin acetate\\nCompound: cephalothin\\nCompound: papaverine\\nCompound: amitriptyline\\nCompound: indomethacin\\nCompound: penicillamine\\nCompound: tamoxifen\\nCompound: furosemide\\nCompound: chlorpromazine\\nCompound: iproniazid\\nCompound: hydroxyzine\\nCompound: cyclosporine A\\nCompound: mexiletine\\nCompound: methimazole\\nCompound: acetamide\\nCompound: chloramphenicol\\nCompound: phalloidin\\nCompound: disopyramide\\nCompound: naproxen\\nCompound: monocrotaline\\nCompound: phenytoin\\nCompound: imipramine\\nCompound: acetaminophen\\nCompound: gentamicin\\nCompound: mefenamic acid\\nCompound: cisplatin\\nCompound: diazepam\\nCompound: phenylbutazone\\nCompound: 1% cholesterol + 0.25% sodium cholate\\nCompound: ketoconazole\\nCompound: phenacetin'], language=None, text=None), status='finished_successfully', end_turn=None, weight=1.0, metadata={'request_id': '860e27512fe26728-AMS', 'timestamp_': 'absolute', 'message_type': None}, recipient='all'), parent='dc35e96e-78eb-434f-ad69-2f84416bb49c', children=['39b657d4-bcfb-42cf-a9f8-871b3b8558f8']), '39b657d4-bcfb-42cf-a9f8-871b3b8558f8': Node(id='39b657d4-bcfb-42cf-a9f8-871b3b8558f8', message=Message(id='39b657d4-bcfb-42cf-a9f8-871b3b8558f8', author=Author(role='assistant', name=None, metadata={}), create_time=1709851939.564363, update_time=None, content=Content(content_type='text', parts=[\"To understand the ordering of these compounds under a functional criterion, we need to consider various possible factors that could influence their arrangement. The list includes a wide range of compounds with differing pharmacological effects, chemical structures, therapeutic uses, and possibly other characteristics. Here's a general approach to reverse engineer the criteria that might have been used:\\n\\n1. **Pharmacological Class/Therapeutic Use**: Compounds might be ordered based on their pharmacological classification or their primary therapeutic use. For example, grouping all antihypertensives, antibiotics, antidiabetics, etc., together.\\n\\n2. **Mechanism of Action**: The compounds might be sorted according to their mechanism of action, grouping those that work similarly, e.g., enzyme inhibitors, channel blockers, receptor agonists or antagonists.\\n\\n3. **Chemical Structure**: The ordering might be based on the chemical structure, where structurally similar compounds are grouped together, such as all compounds with a specific functional group or scaffold.\\n\\n4. **Metabolic Pathway/Toxicity**: The compounds could be organized based on their metabolism, the specific enzymes they interact with, or their toxicity profile.\\n\\n5. **Historical Development**: Sometimes compounds are ordered chronologically, based on their discovery or the introduction into clinical use.\\n\\n6. **Solubility or Stability**: The order might reflect physical or chemical properties like solubility, stability, or formulation types.\\n\\n7. **Regulatory Status**: The arrangement could be influenced by their approval status, such as FDA-approved, withdrawn, experimental, etc.\\n\\n8. **Popularity or Clinical Relevance**: The compounds might be sorted by their prevalence of use in clinical practice or their relevance in current medical treatment guidelines.\\n\\nTo pinpoint the exact criterion used, you would need detailed knowledge of each compound's characteristics. If you have access to more specific data regarding their chemical properties, pharmacokinetics, therapeutic effects, or clinical usage, that could provide significant clues. Additionally, considering the context in which this list is provided (like a specific research focus, textbook chapter, or therapeutic area) could also offer insights into the underlying ordering principle.\"], language=None, text=None), status='finished_successfully', end_turn=True, weight=1.0, metadata={'finish_details': {'type': 'stop', 'stop_tokens': [100260]}, 'citations': [], 'gizmo_id': None, 'is_complete': True, 'message_type': None, 'model_slug': 'gpt-4', 'parent_id': 'aaa2529d-3ccd-4f97-8907-35cddef7bef1', 'request_id': '860e27512fe26728-AMS', 'timestamp_': 'absolute'}, recipient='all'), parent='aaa2529d-3ccd-4f97-8907-35cddef7bef1', children=[]), 'aaa2d260-4979-4b5d-acd7-24d658ade059': Node(id='aaa2d260-4979-4b5d-acd7-24d658ade059', message=Message(id='aaa2d260-4979-4b5d-acd7-24d658ade059', author=Author(role='user', name=None, metadata={}), create_time=1709851981.363171, update_time=None, content=Content(content_type='text', parts=['Help me understand why this compounds have this order. I know for certain they have been ordered under a functional criteria, but I do not know which one or which combinations and I need to try to reverse engineer it. \\nCompound: fluoxetine hydrochloride\\nCompound: labetalol\\nCompound: acarbose\\nCompound: nicotinic acid\\nCompound: ajmaline\\nCompound: carboplatin\\nCompound: ranitidine\\nCompound: benziodarone\\nCompound: butylated hydroxyanisole\\nCompound: danazol\\nCompound: omeprazole\\nCompound: chlormadinone\\nCompound: WY-14643\\nCompound: bendazac\\nCompound: simvastatin\\nCompound: griseofulvin\\nCompound: etoposide\\nCompound: nimesulide\\nCompound: 2,4-dinitrophenol\\nCompound: diclofenac\\nCompound: tiopronin\\nCompound: famotidine\\nCompound: pemoline\\nCompound: cyclophosphamide\\nCompound: triazolam\\nCompound: colchicine\\nCompound: dantrolene\\nCompound: perhexiline\\nCompound: ethanol\\nCompound: erythromycin ethylsuccinate\\nCompound: lomustine\\nCompound: doxorubicin\\nCompound: acetamidofluorene\\nCompound: tacrine\\nCompound: caffeine\\nCompound: captopril\\nCompound: azathioprine\\nCompound: flutamide\\nCompound: aspirin\\nCompound: carbon tetrachloride\\nCompound: nitrofurazone\\nCompound: nitrosodiethylamine\\nCompound: chlormezanone\\nCompound: moxisylyte\\nCompound: isoniazid\\nCompound: rotenone\\nCompound: naphthyl isothiocyanate\\nCompound: metformin\\nCompound: theophylline\\nCompound: sulfasalazine\\nCompound: adapin\\nCompound: nitrofurantoin\\nCompound: sulindac\\nCompound: cimetidine\\nCompound: sulpiride\\nCompound: clofibrate\\nCompound: benzbromarone\\nCompound: amiodarone\\nCompound: rosiglitazone maleate\\nCompound: hexachlorobenzene\\nCompound: propranolol\\nCompound: propylthiouracil\\nCompound: glibenclamide\\nCompound: allyl alcohol\\nCompound: ethionamide\\nCompound: tetracycline\\nCompound: carbamazepine\\nCompound: enalapril\\nCompound: ethinylestradiol\\nCompound: haloperidol\\nCompound: bucetin\\nCompound: ethionine\\nCompound: methapyrilene\\nCompound: methylene dianiline\\nCompound: lornoxicam\\nCompound: fluphenazine\\nCompound: rifampicin\\nCompound: methyldopa\\nCompound: phenylanthranilic acid\\nCompound: disulfiram\\nCompound: quinidine\\nCompound: ticlopidine\\nCompound: puromycin aminonucleoside\\nCompound: promethazine\\nCompound: bromobenzene\\nCompound: thioridazine\\nCompound: ethambutol\\nCompound: gemfibrozil\\nCompound: diltiazem\\nCompound: vitamin A\\nCompound: ciprofloxacin\\nCompound: phenobarbital\\nCompound: methyltestosterone\\nCompound: chlorpropamide\\nCompound: ibuprofen\\nCompound: nifedipine\\nCompound: tolbutamide\\nCompound: thioacetamide\\nCompound: clomipramine\\nCompound: bromoethylamine\\nCompound: trimethadione\\nCompound: coumarin\\nCompound: meloxicam\\nCompound: chlorpheniramine\\nCompound: fenofibrate\\nCompound: valproic acid\\nCompound: acetazolamide\\nCompound: terbinafine\\nCompound: triamterene\\nCompound: allopurinol\\nCompound: amphotericin B\\nCompound: desmopressin acetate\\nCompound: cephalothin\\nCompound: papaverine\\nCompound: amitriptyline\\nCompound: indomethacin\\nCompound: penicillamine\\nCompound: tamoxifen\\nCompound: furosemide\\nCompound: chlorpromazine\\nCompound: iproniazid\\nCompound: hydroxyzine\\nCompound: cyclosporine A\\nCompound: mexiletine\\nCompound: methimazole\\nCompound: acetamide\\nCompound: chloramphenicol\\nCompound: phalloidin\\nCompound: disopyramide\\nCompound: naproxen\\nCompound: monocrotaline\\nCompound: phenytoin\\nCompound: imipramine\\nCompound: acetaminophen\\nCompound: gentamicin\\nCompound: mefenamic acid\\nCompound: cisplatin\\nCompound: diazepam\\nCompound: phenylbutazone\\nCompound: 1% cholesterol + 0.25% sodium cholate\\nCompound: ketoconazole\\nCompound: phenacetin\\ntry to use these criterias Pharmacological Class/Therapeutic Use: Compounds might be ordered based on their pharmacological classification or their primary therapeutic use. For example, grouping all antihypertensives, antibiotics, antidiabetics, etc., together.\\n\\nMechanism of Action: The compounds might be sorted according to their mechanism of action, grouping those that work similarly, e.g., enzyme inhibitors, channel blockers, receptor agonists or antagonists.\\n\\nChemical Structure: The ordering might be based on the chemical structure, where structurally similar compounds are grouped together, such as all compounds with a specific functional group or scaffold.\\n\\nMetabolic Pathway/Toxicity: The compounds could be organized based on their metabolism, the specific enzymes they interact with, or their toxicity profile.\\n\\nHistorical Development: Sometimes compounds are ordered chronologically, based on their discovery or the introduction into clinical use.\\n\\nSolubility or Stability: The order might reflect physical or chemical properties like solubility, stability, or formulation types.\\n\\nRegulatory Status: The arrangement could be influenced by their approval status, such as FDA-approved, withdrawn, experimental, etc.\\n\\nPopularity or Clinical Relevance: The compounds might be sorted by their prevalence of use in clinical practice or their relevance in current medical treatment guidelines. \\n\\nPlese work!!! I need a solution not blabla'], language=None, text=None), status='finished_successfully', end_turn=None, weight=1.0, metadata={'request_id': '860e28bdea7c6728-AMS', 'timestamp_': 'absolute', 'message_type': None}, recipient='all'), parent='dc35e96e-78eb-434f-ad69-2f84416bb49c', children=['b66b110f-ec58-43fd-a3f0-2a766523c0ec']), 'b66b110f-ec58-43fd-a3f0-2a766523c0ec': Node(id='b66b110f-ec58-43fd-a3f0-2a766523c0ec', message=Message(id='b66b110f-ec58-43fd-a3f0-2a766523c0ec', author=Author(role='assistant', name=None, metadata={}), create_time=1709852008.510033, update_time=None, content=Content(content_type='text', parts=[\"To analyze the order of the compounds you've listed and deduce the underlying criteria used, we must consider each suggested criterion and see how well it fits the list of compounds. Given the diversity and number of compounds, this is a complex task that requires a detailed understanding of each compound's properties and classifications. I'll approach this by briefly evaluating the compounds against each of the suggested criteria:\\n\\n1. **Pharmacological Class/Therapeutic Use**: This involves grouping compounds based on their medical application or therapeutic effect, such as antihypertensives, antibiotics, or antidiabetics. If the compounds are ordered this way, we would expect to see clusters of drugs with similar uses together.\\n\\n2. **Mechanism of Action**: Sorting by mechanism involves grouping drugs that work in a similar manner, such as enzyme inhibitors or receptor antagonists. This would require the compounds to be clustered by their biological targets or the pathways they affect.\\n\\n3. **Chemical Structure**: This criterion would organize compounds based on structural similarities, such as specific functional groups or molecular frameworks. Compounds with similar atomic arrangements or functional groups would be expected to be near each other.\\n\\n4. **Metabolic Pathway/Toxicity**: If the compounds are organized by their metabolism or toxicity, they would be grouped based on the metabolic pathways they utilize or the toxic effects they have, which might reflect their safety profiles or organ-specific toxicities.\\n\\n5. **Historical Development**: Ordering by historical development would place compounds in chronological order of their discovery or introduction to clinical practice. This would likely show a mix of drug classes and mechanisms but follow a timeline.\\n\\n6. **Solubility or Stability**: This would group compounds based on their physical and chemical properties, such as water solubility or stability under certain conditions. Compounds with similar solubility profiles or stability characteristics would be grouped.\\n\\n7. **Regulatory Status**: This organizes compounds based on their legal or approval status, such as whether they are FDA-approved, withdrawn, or still experimental. \\n\\n8. **Popularity or Clinical Relevance**: This would sort compounds by their frequency of use in clinical settings or their importance in current medical guidelines.\\n\\nTo accurately determine which of these criteria or combination thereof applies to your list, one would ideally analyze each compound against all these factors. However, this is a massive task requiring extensive data on each compound, typically involving a detailed database or dataset that includes all these attributes for each drug.\\n\\nGiven the complexity and the need for detailed specific information on each compound, the best approach would involve a systematic analysis using a specialized database or software that can categorize and sort these compounds based on the listed criteria. Without access to such detailed pharmacological databases or software tools in this environment, I can provide guidance or suggestions on how you might proceed, but I can't definitively determine the ordering principle for this extensive and varied list of compounds. \\n\\nIf you have access to a database or software that includes detailed information on these compounds, you could input the data and sort it based on each criterion to see which one aligns with the order you have. Alternatively, if there are specific subsets or examples you'd like to explore, we can look into those in more detail.\"], language=None, text=None), status='finished_successfully', end_turn=True, weight=1.0, metadata={'finish_details': {'type': 'stop', 'stop_tokens': [100260]}, 'citations': [], 'gizmo_id': None, 'is_complete': True, 'message_type': None, 'model_slug': 'gpt-4', 'parent_id': 'aaa2d260-4979-4b5d-acd7-24d658ade059', 'request_id': '860e28bdea7c6728-AMS', 'timestamp_': 'absolute'}, recipient='all'), parent='aaa2d260-4979-4b5d-acd7-24d658ade059', children=[]), 'aaa270c8-9410-41ff-a995-8ced8fa2891c': Node(id='aaa270c8-9410-41ff-a995-8ced8fa2891c', message=Message(id='aaa270c8-9410-41ff-a995-8ced8fa2891c', author=Author(role='user', name=None, metadata={}), create_time=1709852031.763697, update_time=None, content=Content(content_type='text', parts=['Help me understand why this compounds have this order. I know for certain they have been ordered under a functional criteria, but I do not know which one or which combinations and I need to try to reverse engineer it. \\nCompound: fluoxetine hydrochloride\\nCompound: labetalol\\nCompound: acarbose\\nCompound: nicotinic acid\\nCompound: ajmaline\\nCompound: carboplatin\\nCompound: ranitidine\\nCompound: benziodarone\\nCompound: butylated hydroxyanisole\\nCompound: danazol\\nCompound: omeprazole\\nCompound: chlormadinone\\nCompound: WY-14643\\nCompound: bendazac\\nCompound: simvastatin\\nCompound: griseofulvin\\nCompound: etoposide\\nCompound: nimesulide\\nCompound: 2,4-dinitrophenol\\nCompound: diclofenac\\nCompound: tiopronin\\nCompound: famotidine\\nCompound: pemoline\\nCompound: cyclophosphamide\\nCompound: triazolam\\nCompound: colchicine\\nCompound: dantrolene\\nCompound: perhexiline\\nCompound: ethanol\\nCompound: erythromycin ethylsuccinate\\nCompound: lomustine\\nCompound: doxorubicin\\nCompound: acetamidofluorene\\nCompound: tacrine\\nCompound: caffeine\\nCompound: captopril\\nCompound: azathioprine\\nCompound: flutamide\\nCompound: aspirin\\nCompound: carbon tetrachloride\\nCompound: nitrofurazone\\nCompound: nitrosodiethylamine\\nCompound: chlormezanone\\nCompound: moxisylyte\\nCompound: isoniazid\\nCompound: rotenone\\nCompound: naphthyl isothiocyanate\\nCompound: metformin\\nCompound: theophylline\\nCompound: sulfasalazine\\nCompound: adapin\\nCompound: nitrofurantoin\\nCompound: sulindac\\nCompound: cimetidine\\nCompound: sulpiride\\nCompound: clofibrate\\nCompound: benzbromarone\\nCompound: amiodarone\\nCompound: rosiglitazone maleate\\nCompound: hexachlorobenzene\\nCompound: propranolol\\nCompound: propylthiouracil\\nCompound: glibenclamide\\nCompound: allyl alcohol\\nCompound: ethionamide\\nCompound: tetracycline\\nCompound: carbamazepine\\nCompound: enalapril\\nCompound: ethinylestradiol\\nCompound: haloperidol\\nCompound: bucetin\\nCompound: ethionine\\nCompound: methapyrilene\\nCompound: methylene dianiline\\nCompound: lornoxicam\\nCompound: fluphenazine\\nCompound: rifampicin\\nCompound: methyldopa\\nCompound: phenylanthranilic acid\\nCompound: disulfiram\\nCompound: quinidine\\nCompound: ticlopidine\\nCompound: puromycin aminonucleoside\\nCompound: promethazine\\nCompound: bromobenzene\\nCompound: thioridazine\\nCompound: ethambutol\\nCompound: gemfibrozil\\nCompound: diltiazem\\nCompound: vitamin A\\nCompound: ciprofloxacin\\nCompound: phenobarbital\\nCompound: methyltestosterone\\nCompound: chlorpropamide\\nCompound: ibuprofen\\nCompound: nifedipine\\nCompound: tolbutamide\\nCompound: thioacetamide\\nCompound: clomipramine\\nCompound: bromoethylamine\\nCompound: trimethadione\\nCompound: coumarin\\nCompound: meloxicam\\nCompound: chlorpheniramine\\nCompound: fenofibrate\\nCompound: valproic acid\\nCompound: acetazolamide\\nCompound: terbinafine\\nCompound: triamterene\\nCompound: allopurinol\\nCompound: amphotericin B\\nCompound: desmopressin acetate\\nCompound: cephalothin\\nCompound: papaverine\\nCompound: amitriptyline\\nCompound: indomethacin\\nCompound: penicillamine\\nCompound: tamoxifen\\nCompound: furosemide\\nCompound: chlorpromazine\\nCompound: iproniazid\\nCompound: hydroxyzine\\nCompound: cyclosporine A\\nCompound: mexiletine\\nCompound: methimazole\\nCompound: acetamide\\nCompound: chloramphenicol\\nCompound: phalloidin\\nCompound: disopyramide\\nCompound: naproxen\\nCompound: monocrotaline\\nCompound: phenytoin\\nCompound: imipramine\\nCompound: acetaminophen\\nCompound: gentamicin\\nCompound: mefenamic acid\\nCompound: cisplatin\\nCompound: diazepam\\nCompound: phenylbutazone\\nCompound: 1% cholesterol + 0.25% sodium cholate\\nCompound: ketoconazole\\nCompound: phenacetin\\ntry to use these criterias Pharmacological Class/Therapeutic Use: Compounds might be ordered based on their pharmacological classification or their primary therapeutic use. For example, grouping all antihypertensives, antibiotics, antidiabetics, etc., together.\\n\\nMechanism of Action: The compounds might be sorted according to their mechanism of action, grouping those that work similarly, e.g., enzyme inhibitors, channel blockers, receptor agonists or antagonists.\\n\\nChemical Structure: The ordering might be based on the chemical structure, where structurally similar compounds are grouped together, such as all compounds with a specific functional group or scaffold.\\n\\nMetabolic Pathway/Toxicity: The compounds could be organized based on their metabolism, the specific enzymes they interact with, or their toxicity profile.\\n\\nHistorical Development: Sometimes compounds are ordered chronologically, based on their discovery or the introduction into clinical use.\\n\\nSolubility or Stability: The order might reflect physical or chemical properties like solubility, stability, or formulation types.\\n\\nRegulatory Status: The arrangement could be influenced by their approval status, such as FDA-approved, withdrawn, experimental, etc.\\n\\nPopularity or Clinical Relevance: The compounds might be sorted by their prevalence of use in clinical practice or their relevance in current medical treatment guidelines. \\n\\nPlese work!!! I need a solution not blabla I need your opinion urgently, it does not matter if it is wrong.'], language=None, text=None), status='finished_successfully', end_turn=None, weight=1.0, metadata={'request_id': '860e29fd8feb6728-AMS', 'timestamp_': 'absolute', 'message_type': None}, recipient='all'), parent='dc35e96e-78eb-434f-ad69-2f84416bb49c', children=['8d96c8d3-6b97-4a8b-889a-8e4185359dfc']), '8d96c8d3-6b97-4a8b-889a-8e4185359dfc': Node(id='8d96c8d3-6b97-4a8b-889a-8e4185359dfc', message=Message(id='8d96c8d3-6b97-4a8b-889a-8e4185359dfc', author=Author(role='assistant', name=None, metadata={}), create_time=1709852062.377428, update_time=None, content=Content(content_type='text', parts=[\"Given the complexity and the vast number of compounds listed, it's quite challenging to pinpoint the exact functional criterion used to order them without additional context. However, I can propose a hypothesis based on the criteria you provided:\\n\\n1. **Pharmacological Class/Therapeutic Use**: This is often a common way to categorize compounds. However, the list includes a wide range of drugs from different therapeutic classes, such as antidepressants (fluoxetine), beta-blockers (labetalol), antidiabetics (metformin), and antibiotics (erythromycin), among others. If they were ordered by this criterion, one would expect to see clusters of drugs with similar uses together, which does not seem to be the case here.\\n\\n2. **Mechanism of Action**: Like pharmacological class, this would group compounds with similar functional mechanisms, such as enzyme inhibitors or receptor antagonists. The list includes a variety of mechanisms, suggesting this might not be the organizing principle either, unless the ordering is highly nuanced.\\n\\n3. **Chemical Structure**: This could be a subtle yet complex way to organize them, especially if the focus is on specific functional groups or molecular scaffolds. However, given the diversity of structures in this list (ranging from small molecules like aspirin to large molecules like proteins), this doesn't immediately stand out as the organizing principle.\\n\\n4. **Metabolic Pathway/Toxicity**: This is plausible, especially if the compounds have been studied extensively in pharmacokinetics or toxicology. However, such a classification would require detailed metabolic or toxicological profiling, which is not apparent from the list alone.\\n\\n5. **Historical Development**: Ordering compounds based on their discovery or clinical introduction is possible, but this list includes both older drugs like penicillin and newer ones like tyrosine kinase inhibitors, not in a clear chronological order.\\n\\n6. **Solubility or Stability**: While important for formulation scientists, this is unlikely to be the criterion unless the list is specifically meant for that audience, as these properties wouldn't usually dictate the order of a general compound list.\\n\\n7. **Regulatory Status**: This would require a clear pattern of approved, withdrawn, experimental compounds, etc., which doesn't seem to be evident here.\\n\\n8. **Popularity or Clinical Relevance**: This is subjective and would vary widely depending on the therapeutic area, geographic region, and current medical trends, making it an unlikely sole criterion for ordering.\\n\\nConsidering these possibilities, it seems that the list might not be organized by a single criterion but could potentially be a combination of factors, or it might represent a dataset from a study where the order is related to specific experimental results or conditions. If the compounds are from a research study, they might be listed in the order they were tested or according to some other study-specific rationale.\\n\\nWithout additional context, such as the source of the list or the field of study it's associated with, it's challenging to determine the exact organizational logic. If you have any more details or a specific context in which this list is used, that could provide crucial clues for a more accurate hypothesis.\"], language=None, text=None), status='finished_successfully', end_turn=True, weight=1.0, metadata={'finish_details': {'type': 'stop', 'stop_tokens': [100260]}, 'citations': [], 'gizmo_id': None, 'is_complete': True, 'message_type': None, 'model_slug': 'gpt-4', 'parent_id': 'aaa270c8-9410-41ff-a995-8ced8fa2891c', 'request_id': '860e29fd8feb6728-AMS', 'timestamp_': 'absolute'}, recipient='all'), parent='aaa270c8-9410-41ff-a995-8ced8fa2891c', children=[])} moderation_results=[] current_node='8d96c8d3-6b97-4a8b-889a-8e4185359dfc' plugin_ids=None conversation_id='ee0ec9ab-eea8-4f30-a223-e97dadc5a103' conversation_template_id=None gizmo_id=None is_archived=False safe_urls=[] id='ee0ec9ab-eea8-4f30-a223-e97dadc5a103'\n",
      "4\n"
     ]
    }
   ],
   "source": [
    "test_instance = Conversation(**test_record)\n",
    "print(test_instance)\n",
    "print(len(test_instance.extract_all_linearized_conversations()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[LinearConversation(title='Functional Criteria for Compound Order', create_time=1709851858.42512, update_time=1709852062.470933, mapping={'aaa15694-6345-43a7-be05-1c5b4f73f9f6': Node(id='aaa15694-6345-43a7-be05-1c5b4f73f9f6', message=None, parent=None, children=['dc35e96e-78eb-434f-ad69-2f84416bb49c']), 'dc35e96e-78eb-434f-ad69-2f84416bb49c': Node(id='dc35e96e-78eb-434f-ad69-2f84416bb49c', message=Message(id='dc35e96e-78eb-434f-ad69-2f84416bb49c', author=Author(role='system', name=None, metadata={}), create_time=None, update_time=None, content=Content(content_type='text', parts=[''], language=None, text=None), status='finished_successfully', end_turn=True, weight=0.0, metadata={'is_visually_hidden_from_conversation': True}, recipient='all'), parent='aaa15694-6345-43a7-be05-1c5b4f73f9f6', children=['aaa239c1-beeb-4101-be6a-3b95dc9b0466']), 'aaa239c1-beeb-4101-be6a-3b95dc9b0466': Node(id='aaa239c1-beeb-4101-be6a-3b95dc9b0466', message=Message(id='aaa239c1-beeb-4101-be6a-3b95dc9b0466', author=Author(role='user', name=None, metadata={}), create_time=1709851858.426031, update_time=None, content=Content(content_type='text', parts=['find a rationale for this compound ordering \\nCompound: fluoxetine hydrochloride\\nCompound: labetalol\\nCompound: acarbose\\nCompound: nicotinic acid\\nCompound: ajmaline\\nCompound: carboplatin\\nCompound: ranitidine\\nCompound: benziodarone\\nCompound: butylated hydroxyanisole\\nCompound: danazol\\nCompound: omeprazole\\nCompound: chlormadinone\\nCompound: WY-14643\\nCompound: bendazac\\nCompound: simvastatin\\nCompound: griseofulvin\\nCompound: etoposide\\nCompound: nimesulide\\nCompound: 2,4-dinitrophenol\\nCompound: diclofenac\\nCompound: tiopronin\\nCompound: famotidine\\nCompound: pemoline\\nCompound: cyclophosphamide\\nCompound: triazolam\\nCompound: colchicine\\nCompound: dantrolene\\nCompound: perhexiline\\nCompound: ethanol\\nCompound: erythromycin ethylsuccinate\\nCompound: lomustine\\nCompound: doxorubicin\\nCompound: acetamidofluorene\\nCompound: tacrine\\nCompound: caffeine\\nCompound: captopril\\nCompound: azathioprine\\nCompound: flutamide\\nCompound: aspirin\\nCompound: carbon tetrachloride\\nCompound: nitrofurazone\\nCompound: nitrosodiethylamine\\nCompound: chlormezanone\\nCompound: moxisylyte\\nCompound: isoniazid\\nCompound: rotenone\\nCompound: naphthyl isothiocyanate\\nCompound: metformin\\nCompound: theophylline\\nCompound: sulfasalazine\\nCompound: adapin\\nCompound: nitrofurantoin\\nCompound: sulindac\\nCompound: cimetidine\\nCompound: sulpiride\\nCompound: clofibrate\\nCompound: benzbromarone\\nCompound: amiodarone\\nCompound: rosiglitazone maleate\\nCompound: hexachlorobenzene\\nCompound: propranolol\\nCompound: propylthiouracil\\nCompound: glibenclamide\\nCompound: allyl alcohol\\nCompound: ethionamide\\nCompound: tetracycline\\nCompound: carbamazepine\\nCompound: enalapril\\nCompound: ethinylestradiol\\nCompound: haloperidol\\nCompound: bucetin\\nCompound: ethionine\\nCompound: methapyrilene\\nCompound: methylene dianiline\\nCompound: lornoxicam\\nCompound: fluphenazine\\nCompound: rifampicin\\nCompound: methyldopa\\nCompound: phenylanthranilic acid\\nCompound: disulfiram\\nCompound: quinidine\\nCompound: ticlopidine\\nCompound: puromycin aminonucleoside\\nCompound: promethazine\\nCompound: bromobenzene\\nCompound: thioridazine\\nCompound: ethambutol\\nCompound: gemfibrozil\\nCompound: diltiazem\\nCompound: vitamin A\\nCompound: ciprofloxacin\\nCompound: phenobarbital\\nCompound: methyltestosterone\\nCompound: chlorpropamide\\nCompound: ibuprofen\\nCompound: nifedipine\\nCompound: tolbutamide\\nCompound: thioacetamide\\nCompound: clomipramine\\nCompound: bromoethylamine\\nCompound: trimethadione\\nCompound: coumarin\\nCompound: meloxicam\\nCompound: chlorpheniramine\\nCompound: fenofibrate\\nCompound: valproic acid\\nCompound: acetazolamide\\nCompound: terbinafine\\nCompound: triamterene\\nCompound: allopurinol\\nCompound: amphotericin B\\nCompound: desmopressin acetate\\nCompound: cephalothin\\nCompound: papaverine\\nCompound: amitriptyline\\nCompound: indomethacin\\nCompound: penicillamine\\nCompound: tamoxifen\\nCompound: furosemide\\nCompound: chlorpromazine\\nCompound: iproniazid\\nCompound: hydroxyzine\\nCompound: cyclosporine A\\nCompound: mexiletine\\nCompound: methimazole\\nCompound: acetamide\\nCompound: chloramphenicol\\nCompound: phalloidin\\nCompound: disopyramide\\nCompound: naproxen\\nCompound: monocrotaline\\nCompound: phenytoin\\nCompound: imipramine\\nCompound: acetaminophen\\nCompound: gentamicin\\nCompound: mefenamic acid\\nCompound: cisplatin\\nCompound: diazepam\\nCompound: phenylbutazone\\nCompound: 1% cholesterol + 0.25% sodium cholate\\nCompound: ketoconazole\\nCompound: phenacetin'], language=None, text=None), status='finished_successfully', end_turn=None, weight=1.0, metadata={'request_id': '860e25c1dc6f6728-AMS', 'timestamp_': 'absolute', 'message_type': None}, recipient='all'), parent='dc35e96e-78eb-434f-ad69-2f84416bb49c', children=['f91699b4-20a4-4b8b-b60c-89c5094cc682']), 'f91699b4-20a4-4b8b-b60c-89c5094cc682': Node(id='f91699b4-20a4-4b8b-b60c-89c5094cc682', message=Message(id='f91699b4-20a4-4b8b-b60c-89c5094cc682', author=Author(role='assistant', name=None, metadata={}), create_time=1709851868.602737, update_time=None, content=Content(content_type='text', parts=[\"Finding a rationale for ordering such a diverse list of compounds like the one you've provided can be challenging because it depends on the context or criteria you want to prioritize. However, I can suggest several possible rationales for organizing this list:\\n\\n1. **Alphabetical Order**: The simplest way is to arrange them alphabetically. This is straightforward and helps in quickly locating a specific compound in the list.\\n\\n2. **Therapeutic Use/Pharmacological Class**: Grouping the compounds based on their therapeutic use or pharmacological class can be useful. For example, grouping all antihypertensives, antibiotics, antidiabetics, or chemotherapeutic agents together.\\n\\n3. **Mechanism of Action**: Organizing the compounds based on their mechanism of action, such as enzyme inhibitors, receptor antagonists, ion channel blockers, etc.\\n\\n4. **Chemical Structure**: Compounds could be categorized based on their chemical structure or the presence of certain functional groups.\\n\\n5. **Toxicity Profile**: Arranging them based on their safety or toxicity profile, from those considered safest to those with high toxicity levels.\\n\\n6. **Clinical Application**: Sorting the compounds based on the range of clinical applications, from those used for common ailments to those\"], language=None, text=None), status='in_progress', end_turn=None, weight=1.0, metadata={'citations': [], 'gizmo_id': None, 'message_type': None, 'model_slug': 'gpt-4', 'parent_id': 'aaa239c1-beeb-4101-be6a-3b95dc9b0466', 'finish_details': {'type': 'interrupted'}, 'request_id': '860e25c1dc6f6728-AMS', 'timestamp_': 'absolute'}, recipient='all'), parent='aaa239c1-beeb-4101-be6a-3b95dc9b0466', children=[])}, moderation_results=[], current_node='8d96c8d3-6b97-4a8b-889a-8e4185359dfc', plugin_ids=None, conversation_id='ee0ec9ab-eea8-4f30-a223-e97dadc5a103', conversation_template_id=None, gizmo_id=None, is_archived=False, safe_urls=[], id='ee0ec9ab-eea8-4f30-a223-e97dadc5a103'),\n",
       " LinearConversation(title='Functional Criteria for Compound Order', create_time=1709851858.42512, update_time=1709852062.470933, mapping={'aaa15694-6345-43a7-be05-1c5b4f73f9f6': Node(id='aaa15694-6345-43a7-be05-1c5b4f73f9f6', message=None, parent=None, children=['dc35e96e-78eb-434f-ad69-2f84416bb49c']), 'aaa2529d-3ccd-4f97-8907-35cddef7bef1': Node(id='aaa2529d-3ccd-4f97-8907-35cddef7bef1', message=Message(id='aaa2529d-3ccd-4f97-8907-35cddef7bef1', author=Author(role='user', name=None, metadata={}), create_time=1709851922.300042, update_time=None, content=Content(content_type='text', parts=['Help me understand why this compounds have this order. I know for certain they have been ordered under a functional criteria, but I do not know which one or which combinations and I need to try to reverse engineer it. \\nCompound: fluoxetine hydrochloride\\nCompound: labetalol\\nCompound: acarbose\\nCompound: nicotinic acid\\nCompound: ajmaline\\nCompound: carboplatin\\nCompound: ranitidine\\nCompound: benziodarone\\nCompound: butylated hydroxyanisole\\nCompound: danazol\\nCompound: omeprazole\\nCompound: chlormadinone\\nCompound: WY-14643\\nCompound: bendazac\\nCompound: simvastatin\\nCompound: griseofulvin\\nCompound: etoposide\\nCompound: nimesulide\\nCompound: 2,4-dinitrophenol\\nCompound: diclofenac\\nCompound: tiopronin\\nCompound: famotidine\\nCompound: pemoline\\nCompound: cyclophosphamide\\nCompound: triazolam\\nCompound: colchicine\\nCompound: dantrolene\\nCompound: perhexiline\\nCompound: ethanol\\nCompound: erythromycin ethylsuccinate\\nCompound: lomustine\\nCompound: doxorubicin\\nCompound: acetamidofluorene\\nCompound: tacrine\\nCompound: caffeine\\nCompound: captopril\\nCompound: azathioprine\\nCompound: flutamide\\nCompound: aspirin\\nCompound: carbon tetrachloride\\nCompound: nitrofurazone\\nCompound: nitrosodiethylamine\\nCompound: chlormezanone\\nCompound: moxisylyte\\nCompound: isoniazid\\nCompound: rotenone\\nCompound: naphthyl isothiocyanate\\nCompound: metformin\\nCompound: theophylline\\nCompound: sulfasalazine\\nCompound: adapin\\nCompound: nitrofurantoin\\nCompound: sulindac\\nCompound: cimetidine\\nCompound: sulpiride\\nCompound: clofibrate\\nCompound: benzbromarone\\nCompound: amiodarone\\nCompound: rosiglitazone maleate\\nCompound: hexachlorobenzene\\nCompound: propranolol\\nCompound: propylthiouracil\\nCompound: glibenclamide\\nCompound: allyl alcohol\\nCompound: ethionamide\\nCompound: tetracycline\\nCompound: carbamazepine\\nCompound: enalapril\\nCompound: ethinylestradiol\\nCompound: haloperidol\\nCompound: bucetin\\nCompound: ethionine\\nCompound: methapyrilene\\nCompound: methylene dianiline\\nCompound: lornoxicam\\nCompound: fluphenazine\\nCompound: rifampicin\\nCompound: methyldopa\\nCompound: phenylanthranilic acid\\nCompound: disulfiram\\nCompound: quinidine\\nCompound: ticlopidine\\nCompound: puromycin aminonucleoside\\nCompound: promethazine\\nCompound: bromobenzene\\nCompound: thioridazine\\nCompound: ethambutol\\nCompound: gemfibrozil\\nCompound: diltiazem\\nCompound: vitamin A\\nCompound: ciprofloxacin\\nCompound: phenobarbital\\nCompound: methyltestosterone\\nCompound: chlorpropamide\\nCompound: ibuprofen\\nCompound: nifedipine\\nCompound: tolbutamide\\nCompound: thioacetamide\\nCompound: clomipramine\\nCompound: bromoethylamine\\nCompound: trimethadione\\nCompound: coumarin\\nCompound: meloxicam\\nCompound: chlorpheniramine\\nCompound: fenofibrate\\nCompound: valproic acid\\nCompound: acetazolamide\\nCompound: terbinafine\\nCompound: triamterene\\nCompound: allopurinol\\nCompound: amphotericin B\\nCompound: desmopressin acetate\\nCompound: cephalothin\\nCompound: papaverine\\nCompound: amitriptyline\\nCompound: indomethacin\\nCompound: penicillamine\\nCompound: tamoxifen\\nCompound: furosemide\\nCompound: chlorpromazine\\nCompound: iproniazid\\nCompound: hydroxyzine\\nCompound: cyclosporine A\\nCompound: mexiletine\\nCompound: methimazole\\nCompound: acetamide\\nCompound: chloramphenicol\\nCompound: phalloidin\\nCompound: disopyramide\\nCompound: naproxen\\nCompound: monocrotaline\\nCompound: phenytoin\\nCompound: imipramine\\nCompound: acetaminophen\\nCompound: gentamicin\\nCompound: mefenamic acid\\nCompound: cisplatin\\nCompound: diazepam\\nCompound: phenylbutazone\\nCompound: 1% cholesterol + 0.25% sodium cholate\\nCompound: ketoconazole\\nCompound: phenacetin'], language=None, text=None), status='finished_successfully', end_turn=None, weight=1.0, metadata={'request_id': '860e27512fe26728-AMS', 'timestamp_': 'absolute', 'message_type': None}, recipient='all'), parent='dc35e96e-78eb-434f-ad69-2f84416bb49c', children=['39b657d4-bcfb-42cf-a9f8-871b3b8558f8']), '39b657d4-bcfb-42cf-a9f8-871b3b8558f8': Node(id='39b657d4-bcfb-42cf-a9f8-871b3b8558f8', message=Message(id='39b657d4-bcfb-42cf-a9f8-871b3b8558f8', author=Author(role='assistant', name=None, metadata={}), create_time=1709851939.564363, update_time=None, content=Content(content_type='text', parts=[\"To understand the ordering of these compounds under a functional criterion, we need to consider various possible factors that could influence their arrangement. The list includes a wide range of compounds with differing pharmacological effects, chemical structures, therapeutic uses, and possibly other characteristics. Here's a general approach to reverse engineer the criteria that might have been used:\\n\\n1. **Pharmacological Class/Therapeutic Use**: Compounds might be ordered based on their pharmacological classification or their primary therapeutic use. For example, grouping all antihypertensives, antibiotics, antidiabetics, etc., together.\\n\\n2. **Mechanism of Action**: The compounds might be sorted according to their mechanism of action, grouping those that work similarly, e.g., enzyme inhibitors, channel blockers, receptor agonists or antagonists.\\n\\n3. **Chemical Structure**: The ordering might be based on the chemical structure, where structurally similar compounds are grouped together, such as all compounds with a specific functional group or scaffold.\\n\\n4. **Metabolic Pathway/Toxicity**: The compounds could be organized based on their metabolism, the specific enzymes they interact with, or their toxicity profile.\\n\\n5. **Historical Development**: Sometimes compounds are ordered chronologically, based on their discovery or the introduction into clinical use.\\n\\n6. **Solubility or Stability**: The order might reflect physical or chemical properties like solubility, stability, or formulation types.\\n\\n7. **Regulatory Status**: The arrangement could be influenced by their approval status, such as FDA-approved, withdrawn, experimental, etc.\\n\\n8. **Popularity or Clinical Relevance**: The compounds might be sorted by their prevalence of use in clinical practice or their relevance in current medical treatment guidelines.\\n\\nTo pinpoint the exact criterion used, you would need detailed knowledge of each compound's characteristics. If you have access to more specific data regarding their chemical properties, pharmacokinetics, therapeutic effects, or clinical usage, that could provide significant clues. Additionally, considering the context in which this list is provided (like a specific research focus, textbook chapter, or therapeutic area) could also offer insights into the underlying ordering principle.\"], language=None, text=None), status='finished_successfully', end_turn=True, weight=1.0, metadata={'finish_details': {'type': 'stop', 'stop_tokens': [100260]}, 'citations': [], 'gizmo_id': None, 'is_complete': True, 'message_type': None, 'model_slug': 'gpt-4', 'parent_id': 'aaa2529d-3ccd-4f97-8907-35cddef7bef1', 'request_id': '860e27512fe26728-AMS', 'timestamp_': 'absolute'}, recipient='all'), parent='aaa2529d-3ccd-4f97-8907-35cddef7bef1', children=[])}, moderation_results=[], current_node='8d96c8d3-6b97-4a8b-889a-8e4185359dfc', plugin_ids=None, conversation_id='ee0ec9ab-eea8-4f30-a223-e97dadc5a103', conversation_template_id=None, gizmo_id=None, is_archived=False, safe_urls=[], id='ee0ec9ab-eea8-4f30-a223-e97dadc5a103'),\n",
       " LinearConversation(title='Functional Criteria for Compound Order', create_time=1709851858.42512, update_time=1709852062.470933, mapping={'aaa15694-6345-43a7-be05-1c5b4f73f9f6': Node(id='aaa15694-6345-43a7-be05-1c5b4f73f9f6', message=None, parent=None, children=['dc35e96e-78eb-434f-ad69-2f84416bb49c']), 'aaa2d260-4979-4b5d-acd7-24d658ade059': Node(id='aaa2d260-4979-4b5d-acd7-24d658ade059', message=Message(id='aaa2d260-4979-4b5d-acd7-24d658ade059', author=Author(role='user', name=None, metadata={}), create_time=1709851981.363171, update_time=None, content=Content(content_type='text', parts=['Help me understand why this compounds have this order. I know for certain they have been ordered under a functional criteria, but I do not know which one or which combinations and I need to try to reverse engineer it. \\nCompound: fluoxetine hydrochloride\\nCompound: labetalol\\nCompound: acarbose\\nCompound: nicotinic acid\\nCompound: ajmaline\\nCompound: carboplatin\\nCompound: ranitidine\\nCompound: benziodarone\\nCompound: butylated hydroxyanisole\\nCompound: danazol\\nCompound: omeprazole\\nCompound: chlormadinone\\nCompound: WY-14643\\nCompound: bendazac\\nCompound: simvastatin\\nCompound: griseofulvin\\nCompound: etoposide\\nCompound: nimesulide\\nCompound: 2,4-dinitrophenol\\nCompound: diclofenac\\nCompound: tiopronin\\nCompound: famotidine\\nCompound: pemoline\\nCompound: cyclophosphamide\\nCompound: triazolam\\nCompound: colchicine\\nCompound: dantrolene\\nCompound: perhexiline\\nCompound: ethanol\\nCompound: erythromycin ethylsuccinate\\nCompound: lomustine\\nCompound: doxorubicin\\nCompound: acetamidofluorene\\nCompound: tacrine\\nCompound: caffeine\\nCompound: captopril\\nCompound: azathioprine\\nCompound: flutamide\\nCompound: aspirin\\nCompound: carbon tetrachloride\\nCompound: nitrofurazone\\nCompound: nitrosodiethylamine\\nCompound: chlormezanone\\nCompound: moxisylyte\\nCompound: isoniazid\\nCompound: rotenone\\nCompound: naphthyl isothiocyanate\\nCompound: metformin\\nCompound: theophylline\\nCompound: sulfasalazine\\nCompound: adapin\\nCompound: nitrofurantoin\\nCompound: sulindac\\nCompound: cimetidine\\nCompound: sulpiride\\nCompound: clofibrate\\nCompound: benzbromarone\\nCompound: amiodarone\\nCompound: rosiglitazone maleate\\nCompound: hexachlorobenzene\\nCompound: propranolol\\nCompound: propylthiouracil\\nCompound: glibenclamide\\nCompound: allyl alcohol\\nCompound: ethionamide\\nCompound: tetracycline\\nCompound: carbamazepine\\nCompound: enalapril\\nCompound: ethinylestradiol\\nCompound: haloperidol\\nCompound: bucetin\\nCompound: ethionine\\nCompound: methapyrilene\\nCompound: methylene dianiline\\nCompound: lornoxicam\\nCompound: fluphenazine\\nCompound: rifampicin\\nCompound: methyldopa\\nCompound: phenylanthranilic acid\\nCompound: disulfiram\\nCompound: quinidine\\nCompound: ticlopidine\\nCompound: puromycin aminonucleoside\\nCompound: promethazine\\nCompound: bromobenzene\\nCompound: thioridazine\\nCompound: ethambutol\\nCompound: gemfibrozil\\nCompound: diltiazem\\nCompound: vitamin A\\nCompound: ciprofloxacin\\nCompound: phenobarbital\\nCompound: methyltestosterone\\nCompound: chlorpropamide\\nCompound: ibuprofen\\nCompound: nifedipine\\nCompound: tolbutamide\\nCompound: thioacetamide\\nCompound: clomipramine\\nCompound: bromoethylamine\\nCompound: trimethadione\\nCompound: coumarin\\nCompound: meloxicam\\nCompound: chlorpheniramine\\nCompound: fenofibrate\\nCompound: valproic acid\\nCompound: acetazolamide\\nCompound: terbinafine\\nCompound: triamterene\\nCompound: allopurinol\\nCompound: amphotericin B\\nCompound: desmopressin acetate\\nCompound: cephalothin\\nCompound: papaverine\\nCompound: amitriptyline\\nCompound: indomethacin\\nCompound: penicillamine\\nCompound: tamoxifen\\nCompound: furosemide\\nCompound: chlorpromazine\\nCompound: iproniazid\\nCompound: hydroxyzine\\nCompound: cyclosporine A\\nCompound: mexiletine\\nCompound: methimazole\\nCompound: acetamide\\nCompound: chloramphenicol\\nCompound: phalloidin\\nCompound: disopyramide\\nCompound: naproxen\\nCompound: monocrotaline\\nCompound: phenytoin\\nCompound: imipramine\\nCompound: acetaminophen\\nCompound: gentamicin\\nCompound: mefenamic acid\\nCompound: cisplatin\\nCompound: diazepam\\nCompound: phenylbutazone\\nCompound: 1% cholesterol + 0.25% sodium cholate\\nCompound: ketoconazole\\nCompound: phenacetin\\ntry to use these criterias Pharmacological Class/Therapeutic Use: Compounds might be ordered based on their pharmacological classification or their primary therapeutic use. For example, grouping all antihypertensives, antibiotics, antidiabetics, etc., together.\\n\\nMechanism of Action: The compounds might be sorted according to their mechanism of action, grouping those that work similarly, e.g., enzyme inhibitors, channel blockers, receptor agonists or antagonists.\\n\\nChemical Structure: The ordering might be based on the chemical structure, where structurally similar compounds are grouped together, such as all compounds with a specific functional group or scaffold.\\n\\nMetabolic Pathway/Toxicity: The compounds could be organized based on their metabolism, the specific enzymes they interact with, or their toxicity profile.\\n\\nHistorical Development: Sometimes compounds are ordered chronologically, based on their discovery or the introduction into clinical use.\\n\\nSolubility or Stability: The order might reflect physical or chemical properties like solubility, stability, or formulation types.\\n\\nRegulatory Status: The arrangement could be influenced by their approval status, such as FDA-approved, withdrawn, experimental, etc.\\n\\nPopularity or Clinical Relevance: The compounds might be sorted by their prevalence of use in clinical practice or their relevance in current medical treatment guidelines. \\n\\nPlese work!!! I need a solution not blabla'], language=None, text=None), status='finished_successfully', end_turn=None, weight=1.0, metadata={'request_id': '860e28bdea7c6728-AMS', 'timestamp_': 'absolute', 'message_type': None}, recipient='all'), parent='dc35e96e-78eb-434f-ad69-2f84416bb49c', children=['b66b110f-ec58-43fd-a3f0-2a766523c0ec']), 'b66b110f-ec58-43fd-a3f0-2a766523c0ec': Node(id='b66b110f-ec58-43fd-a3f0-2a766523c0ec', message=Message(id='b66b110f-ec58-43fd-a3f0-2a766523c0ec', author=Author(role='assistant', name=None, metadata={}), create_time=1709852008.510033, update_time=None, content=Content(content_type='text', parts=[\"To analyze the order of the compounds you've listed and deduce the underlying criteria used, we must consider each suggested criterion and see how well it fits the list of compounds. Given the diversity and number of compounds, this is a complex task that requires a detailed understanding of each compound's properties and classifications. I'll approach this by briefly evaluating the compounds against each of the suggested criteria:\\n\\n1. **Pharmacological Class/Therapeutic Use**: This involves grouping compounds based on their medical application or therapeutic effect, such as antihypertensives, antibiotics, or antidiabetics. If the compounds are ordered this way, we would expect to see clusters of drugs with similar uses together.\\n\\n2. **Mechanism of Action**: Sorting by mechanism involves grouping drugs that work in a similar manner, such as enzyme inhibitors or receptor antagonists. This would require the compounds to be clustered by their biological targets or the pathways they affect.\\n\\n3. **Chemical Structure**: This criterion would organize compounds based on structural similarities, such as specific functional groups or molecular frameworks. Compounds with similar atomic arrangements or functional groups would be expected to be near each other.\\n\\n4. **Metabolic Pathway/Toxicity**: If the compounds are organized by their metabolism or toxicity, they would be grouped based on the metabolic pathways they utilize or the toxic effects they have, which might reflect their safety profiles or organ-specific toxicities.\\n\\n5. **Historical Development**: Ordering by historical development would place compounds in chronological order of their discovery or introduction to clinical practice. This would likely show a mix of drug classes and mechanisms but follow a timeline.\\n\\n6. **Solubility or Stability**: This would group compounds based on their physical and chemical properties, such as water solubility or stability under certain conditions. Compounds with similar solubility profiles or stability characteristics would be grouped.\\n\\n7. **Regulatory Status**: This organizes compounds based on their legal or approval status, such as whether they are FDA-approved, withdrawn, or still experimental. \\n\\n8. **Popularity or Clinical Relevance**: This would sort compounds by their frequency of use in clinical settings or their importance in current medical guidelines.\\n\\nTo accurately determine which of these criteria or combination thereof applies to your list, one would ideally analyze each compound against all these factors. However, this is a massive task requiring extensive data on each compound, typically involving a detailed database or dataset that includes all these attributes for each drug.\\n\\nGiven the complexity and the need for detailed specific information on each compound, the best approach would involve a systematic analysis using a specialized database or software that can categorize and sort these compounds based on the listed criteria. Without access to such detailed pharmacological databases or software tools in this environment, I can provide guidance or suggestions on how you might proceed, but I can't definitively determine the ordering principle for this extensive and varied list of compounds. \\n\\nIf you have access to a database or software that includes detailed information on these compounds, you could input the data and sort it based on each criterion to see which one aligns with the order you have. Alternatively, if there are specific subsets or examples you'd like to explore, we can look into those in more detail.\"], language=None, text=None), status='finished_successfully', end_turn=True, weight=1.0, metadata={'finish_details': {'type': 'stop', 'stop_tokens': [100260]}, 'citations': [], 'gizmo_id': None, 'is_complete': True, 'message_type': None, 'model_slug': 'gpt-4', 'parent_id': 'aaa2d260-4979-4b5d-acd7-24d658ade059', 'request_id': '860e28bdea7c6728-AMS', 'timestamp_': 'absolute'}, recipient='all'), parent='aaa2d260-4979-4b5d-acd7-24d658ade059', children=[])}, moderation_results=[], current_node='8d96c8d3-6b97-4a8b-889a-8e4185359dfc', plugin_ids=None, conversation_id='ee0ec9ab-eea8-4f30-a223-e97dadc5a103', conversation_template_id=None, gizmo_id=None, is_archived=False, safe_urls=[], id='ee0ec9ab-eea8-4f30-a223-e97dadc5a103'),\n",
       " LinearConversation(title='Functional Criteria for Compound Order', create_time=1709851858.42512, update_time=1709852062.470933, mapping={'aaa15694-6345-43a7-be05-1c5b4f73f9f6': Node(id='aaa15694-6345-43a7-be05-1c5b4f73f9f6', message=None, parent=None, children=['dc35e96e-78eb-434f-ad69-2f84416bb49c']), 'aaa270c8-9410-41ff-a995-8ced8fa2891c': Node(id='aaa270c8-9410-41ff-a995-8ced8fa2891c', message=Message(id='aaa270c8-9410-41ff-a995-8ced8fa2891c', author=Author(role='user', name=None, metadata={}), create_time=1709852031.763697, update_time=None, content=Content(content_type='text', parts=['Help me understand why this compounds have this order. I know for certain they have been ordered under a functional criteria, but I do not know which one or which combinations and I need to try to reverse engineer it. \\nCompound: fluoxetine hydrochloride\\nCompound: labetalol\\nCompound: acarbose\\nCompound: nicotinic acid\\nCompound: ajmaline\\nCompound: carboplatin\\nCompound: ranitidine\\nCompound: benziodarone\\nCompound: butylated hydroxyanisole\\nCompound: danazol\\nCompound: omeprazole\\nCompound: chlormadinone\\nCompound: WY-14643\\nCompound: bendazac\\nCompound: simvastatin\\nCompound: griseofulvin\\nCompound: etoposide\\nCompound: nimesulide\\nCompound: 2,4-dinitrophenol\\nCompound: diclofenac\\nCompound: tiopronin\\nCompound: famotidine\\nCompound: pemoline\\nCompound: cyclophosphamide\\nCompound: triazolam\\nCompound: colchicine\\nCompound: dantrolene\\nCompound: perhexiline\\nCompound: ethanol\\nCompound: erythromycin ethylsuccinate\\nCompound: lomustine\\nCompound: doxorubicin\\nCompound: acetamidofluorene\\nCompound: tacrine\\nCompound: caffeine\\nCompound: captopril\\nCompound: azathioprine\\nCompound: flutamide\\nCompound: aspirin\\nCompound: carbon tetrachloride\\nCompound: nitrofurazone\\nCompound: nitrosodiethylamine\\nCompound: chlormezanone\\nCompound: moxisylyte\\nCompound: isoniazid\\nCompound: rotenone\\nCompound: naphthyl isothiocyanate\\nCompound: metformin\\nCompound: theophylline\\nCompound: sulfasalazine\\nCompound: adapin\\nCompound: nitrofurantoin\\nCompound: sulindac\\nCompound: cimetidine\\nCompound: sulpiride\\nCompound: clofibrate\\nCompound: benzbromarone\\nCompound: amiodarone\\nCompound: rosiglitazone maleate\\nCompound: hexachlorobenzene\\nCompound: propranolol\\nCompound: propylthiouracil\\nCompound: glibenclamide\\nCompound: allyl alcohol\\nCompound: ethionamide\\nCompound: tetracycline\\nCompound: carbamazepine\\nCompound: enalapril\\nCompound: ethinylestradiol\\nCompound: haloperidol\\nCompound: bucetin\\nCompound: ethionine\\nCompound: methapyrilene\\nCompound: methylene dianiline\\nCompound: lornoxicam\\nCompound: fluphenazine\\nCompound: rifampicin\\nCompound: methyldopa\\nCompound: phenylanthranilic acid\\nCompound: disulfiram\\nCompound: quinidine\\nCompound: ticlopidine\\nCompound: puromycin aminonucleoside\\nCompound: promethazine\\nCompound: bromobenzene\\nCompound: thioridazine\\nCompound: ethambutol\\nCompound: gemfibrozil\\nCompound: diltiazem\\nCompound: vitamin A\\nCompound: ciprofloxacin\\nCompound: phenobarbital\\nCompound: methyltestosterone\\nCompound: chlorpropamide\\nCompound: ibuprofen\\nCompound: nifedipine\\nCompound: tolbutamide\\nCompound: thioacetamide\\nCompound: clomipramine\\nCompound: bromoethylamine\\nCompound: trimethadione\\nCompound: coumarin\\nCompound: meloxicam\\nCompound: chlorpheniramine\\nCompound: fenofibrate\\nCompound: valproic acid\\nCompound: acetazolamide\\nCompound: terbinafine\\nCompound: triamterene\\nCompound: allopurinol\\nCompound: amphotericin B\\nCompound: desmopressin acetate\\nCompound: cephalothin\\nCompound: papaverine\\nCompound: amitriptyline\\nCompound: indomethacin\\nCompound: penicillamine\\nCompound: tamoxifen\\nCompound: furosemide\\nCompound: chlorpromazine\\nCompound: iproniazid\\nCompound: hydroxyzine\\nCompound: cyclosporine A\\nCompound: mexiletine\\nCompound: methimazole\\nCompound: acetamide\\nCompound: chloramphenicol\\nCompound: phalloidin\\nCompound: disopyramide\\nCompound: naproxen\\nCompound: monocrotaline\\nCompound: phenytoin\\nCompound: imipramine\\nCompound: acetaminophen\\nCompound: gentamicin\\nCompound: mefenamic acid\\nCompound: cisplatin\\nCompound: diazepam\\nCompound: phenylbutazone\\nCompound: 1% cholesterol + 0.25% sodium cholate\\nCompound: ketoconazole\\nCompound: phenacetin\\ntry to use these criterias Pharmacological Class/Therapeutic Use: Compounds might be ordered based on their pharmacological classification or their primary therapeutic use. For example, grouping all antihypertensives, antibiotics, antidiabetics, etc., together.\\n\\nMechanism of Action: The compounds might be sorted according to their mechanism of action, grouping those that work similarly, e.g., enzyme inhibitors, channel blockers, receptor agonists or antagonists.\\n\\nChemical Structure: The ordering might be based on the chemical structure, where structurally similar compounds are grouped together, such as all compounds with a specific functional group or scaffold.\\n\\nMetabolic Pathway/Toxicity: The compounds could be organized based on their metabolism, the specific enzymes they interact with, or their toxicity profile.\\n\\nHistorical Development: Sometimes compounds are ordered chronologically, based on their discovery or the introduction into clinical use.\\n\\nSolubility or Stability: The order might reflect physical or chemical properties like solubility, stability, or formulation types.\\n\\nRegulatory Status: The arrangement could be influenced by their approval status, such as FDA-approved, withdrawn, experimental, etc.\\n\\nPopularity or Clinical Relevance: The compounds might be sorted by their prevalence of use in clinical practice or their relevance in current medical treatment guidelines. \\n\\nPlese work!!! I need a solution not blabla I need your opinion urgently, it does not matter if it is wrong.'], language=None, text=None), status='finished_successfully', end_turn=None, weight=1.0, metadata={'request_id': '860e29fd8feb6728-AMS', 'timestamp_': 'absolute', 'message_type': None}, recipient='all'), parent='dc35e96e-78eb-434f-ad69-2f84416bb49c', children=['8d96c8d3-6b97-4a8b-889a-8e4185359dfc']), '8d96c8d3-6b97-4a8b-889a-8e4185359dfc': Node(id='8d96c8d3-6b97-4a8b-889a-8e4185359dfc', message=Message(id='8d96c8d3-6b97-4a8b-889a-8e4185359dfc', author=Author(role='assistant', name=None, metadata={}), create_time=1709852062.377428, update_time=None, content=Content(content_type='text', parts=[\"Given the complexity and the vast number of compounds listed, it's quite challenging to pinpoint the exact functional criterion used to order them without additional context. However, I can propose a hypothesis based on the criteria you provided:\\n\\n1. **Pharmacological Class/Therapeutic Use**: This is often a common way to categorize compounds. However, the list includes a wide range of drugs from different therapeutic classes, such as antidepressants (fluoxetine), beta-blockers (labetalol), antidiabetics (metformin), and antibiotics (erythromycin), among others. If they were ordered by this criterion, one would expect to see clusters of drugs with similar uses together, which does not seem to be the case here.\\n\\n2. **Mechanism of Action**: Like pharmacological class, this would group compounds with similar functional mechanisms, such as enzyme inhibitors or receptor antagonists. The list includes a variety of mechanisms, suggesting this might not be the organizing principle either, unless the ordering is highly nuanced.\\n\\n3. **Chemical Structure**: This could be a subtle yet complex way to organize them, especially if the focus is on specific functional groups or molecular scaffolds. However, given the diversity of structures in this list (ranging from small molecules like aspirin to large molecules like proteins), this doesn't immediately stand out as the organizing principle.\\n\\n4. **Metabolic Pathway/Toxicity**: This is plausible, especially if the compounds have been studied extensively in pharmacokinetics or toxicology. However, such a classification would require detailed metabolic or toxicological profiling, which is not apparent from the list alone.\\n\\n5. **Historical Development**: Ordering compounds based on their discovery or clinical introduction is possible, but this list includes both older drugs like penicillin and newer ones like tyrosine kinase inhibitors, not in a clear chronological order.\\n\\n6. **Solubility or Stability**: While important for formulation scientists, this is unlikely to be the criterion unless the list is specifically meant for that audience, as these properties wouldn't usually dictate the order of a general compound list.\\n\\n7. **Regulatory Status**: This would require a clear pattern of approved, withdrawn, experimental compounds, etc., which doesn't seem to be evident here.\\n\\n8. **Popularity or Clinical Relevance**: This is subjective and would vary widely depending on the therapeutic area, geographic region, and current medical trends, making it an unlikely sole criterion for ordering.\\n\\nConsidering these possibilities, it seems that the list might not be organized by a single criterion but could potentially be a combination of factors, or it might represent a dataset from a study where the order is related to specific experimental results or conditions. If the compounds are from a research study, they might be listed in the order they were tested or according to some other study-specific rationale.\\n\\nWithout additional context, such as the source of the list or the field of study it's associated with, it's challenging to determine the exact organizational logic. If you have any more details or a specific context in which this list is used, that could provide crucial clues for a more accurate hypothesis.\"], language=None, text=None), status='finished_successfully', end_turn=True, weight=1.0, metadata={'finish_details': {'type': 'stop', 'stop_tokens': [100260]}, 'citations': [], 'gizmo_id': None, 'is_complete': True, 'message_type': None, 'model_slug': 'gpt-4', 'parent_id': 'aaa270c8-9410-41ff-a995-8ced8fa2891c', 'request_id': '860e29fd8feb6728-AMS', 'timestamp_': 'absolute'}, recipient='all'), parent='aaa270c8-9410-41ff-a995-8ced8fa2891c', children=[])}, moderation_results=[], current_node='8d96c8d3-6b97-4a8b-889a-8e4185359dfc', plugin_ids=None, conversation_id='ee0ec9ab-eea8-4f30-a223-e97dadc5a103', conversation_template_id=None, gizmo_id=None, is_archived=False, safe_urls=[], id='ee0ec9ab-eea8-4f30-a223-e97dadc5a103')]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_instance.extract_all_linearized_conversations()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "test_instance.visualize_conversation()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "import erdantic as erd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "erd.draw(Conversation, out = 'gang.png')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
